Sentence	entity_1	entity_2	entity_3	entity_4	entity_5	entity_6	entity_7	entity_8	entity_9	entity_10	entity_11	json	split
qPCR was performed using the 7900 Sequence Detection System ( Applied Biosystems ), with the following gene - specific primers: phosphoglycerate kinase 1 ( PGK1, forward: 5 ′- ctgctgttccaagcatcaaa - 3 ′ reverse: 5 ′- gcatcttttcccttcccttc - 3 ′), glial fibrillary acidic protein ( GFAP, forward: 5 ′- acgcttctccttgtctcgaa - 3 ′ reverse: 5 ′- cggcgatagtcgttagcttc - 3 ′), ionized calcium binding adapter molecule 1 ( Iba1, forward: 5 ′- atgagccaaagcagggattt - 3 ′ reverse: 5 ′- gaccagttggcctcttgtgt - 3 ′), NOD - like receptor family, pyrin domain containing 3 ( NLRP3, forward: 5 ′- ccttggaccaggttcagtgt - 3 ′ reverse: 5 ′- aggagatgtcgaagcagcat - 3 ′), purinergic receptor P2X ligand - gated ion channel 7 ( P2X7R, forward: 5 ′- tgtgtgcattgacttgctca - 3 ′ reverse: 5 ′- cttgcagacttttcccaagc - 3 ′) Interleukin - 1 beta ( IL - 1β, forward: 5 ′- gaccttccaggatgaggaca - 3 ′ reverse: 5 ′- aggccacaggtattttgtcg - 3 ′).	phosphoglycerate kinase 1,128,153,Gene/Protein	PGK1,156,160,Gene/Protein	glial fibrillary acidic protein,246,277,Gene/Protein	GFAP,280,284,Gene/Protein	ionized calcium binding adapter molecule 1,370,412,Gene/Protein	Iba1,415,419,Gene/Protein	NLRP3,561,566,Gene/Protein	purinergic receptor P2X ligand - gated ion channel 7,652,704,Gene/Protein	P2X7R,707,712,Gene/Protein	Interleukin - 1 beta,797,817,Gene/Protein	IL - 1β,820,827,Gene/Protein	"[{""token"": ""phosphoglycerate kinase 1"", ""start_span"": 128, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""PGK1"", ""start_span"": 156, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""glial fibrillary acidic protein"", ""start_span"": 246, ""end_span"": 277, ""type"": ""Gene/Protein""}, {""token"": ""GFAP"", ""start_span"": 280, ""end_span"": 284, ""type"": ""Gene/Protein""}, {""token"": ""ionized calcium binding adapter molecule 1"", ""start_span"": 370, ""end_span"": 412, ""type"": ""Gene/Protein""}, {""token"": ""Iba1"", ""start_span"": 415, ""end_span"": 419, ""type"": ""Gene/Protein""}, {""token"": ""NLRP3"", ""start_span"": 561, ""end_span"": 566, ""type"": ""Gene/Protein""}, {""token"": ""purinergic receptor P2X ligand - gated ion channel 7"", ""start_span"": 652, ""end_span"": 704, ""type"": ""Gene/Protein""}, {""token"": ""P2X7R"", ""start_span"": 707, ""end_span"": 712, ""type"": ""Gene/Protein""}, {""token"": ""Interleukin - 1 beta"", ""start_span"": 797, ""end_span"": 817, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1\u03b2"", ""start_span"": 820, ""end_span"": 827, ""type"": ""Gene/Protein""}]"	test
Of note, whilst HZ and PHN are associated with higher costs to healthcare providers in elderly populations, costs to society in terms of time missed for work tends to be lower, so the total costs overall are similar across age groups [ 60 ]. Table 5 Mean total cost of management per HZ or PHN case Country Population age Cost per case HZ PHN1 * PHN3 ^ Belgium [ 26] Aged ≥ 50 € 118 ( no pain )€ 156. 94 ( mild pain )€ 329. 22 ( mild pain )€ 1, 150. 50 ( severe pain )€ 1, 085. 60 ( severe pain )€ 2, 037. 86 ( severe pain) France [ 30] Aged ≥ 50 € 419. 87 ( 271 – 586 )€ 672. 76 ( 451 – 968 )- Germany [ 31] Aged ≥ 50 € 388. 30 ( 354 – 425 )-€ 1, 427. 80 ( 1, 002 - 1, 917) Germany [ 67] Aged ≥ 50 € 729. 57 € 2, 167. 89Italy [ 29] Aged ≥ 50 € 888. 06 -€ 1, 66. 65Spain [ 27] Aged > 14 Overall: € 446. 04 ( SD 508. 58 )€ 647. 82 ( SD 684. 4 )€ 968. 78 ( SD 803. 58) 50 - 59: € 282. 06 ( SD 273. 15) 60 - 69 :€ 510. 52 ( SD 512. 73) > 70: € 422. 91 ( SD 388. 66) Spain [ 69] Aged > 30 € 460. 95 € 1, 956. 15 - Sweden [ 63] All ages € 902. 88 ( HZ and PHN) Switzerland [ 72] Aged ≥ 50 € 394. 46 ( no pain )-€ 381. 15 ( no pain )€ 1, 835. 57 ( severe pain )€ 2, 442. 99 ( severe pain) UK [ 7] Not specified € 793. 60 ( 31 – 6, 394 )--( all ages) Aged + 65: € 788. 48 * PHN defined as pain persisting for one month following resolution of HZ rash .^ PHN defined as pain persisting for three months following resolution of HZ rash.	HZ,16,18,Disease/Disorder	PHN,23,26,Disease/Disorder	HZ,284,286,Disease/Disorder	PHN,290,293,Disease/Disorder	HZ,336,338,Disease/Disorder	HZ,1044,1046,Disease/Disorder	PHN,1051,1054,Disease/Disorder	PHN,1267,1270,Disease/Disorder	HZ,1336,1338,Disease/Disorder	PHN,1347,1350,Disease/Disorder	HZ,1419,1421,Disease/Disorder	"[{""token"": ""HZ"", ""start_span"": 16, ""end_span"": 18, ""type"": ""Disease/Disorder""}, {""token"": ""PHN"", ""start_span"": 23, ""end_span"": 26, ""type"": ""Disease/Disorder""}, {""token"": ""HZ"", ""start_span"": 284, ""end_span"": 286, ""type"": ""Disease/Disorder""}, {""token"": ""PHN"", ""start_span"": 290, ""end_span"": 293, ""type"": ""Disease/Disorder""}, {""token"": ""HZ"", ""start_span"": 336, ""end_span"": 338, ""type"": ""Disease/Disorder""}, {""token"": ""HZ"", ""start_span"": 1044, ""end_span"": 1046, ""type"": ""Disease/Disorder""}, {""token"": ""PHN"", ""start_span"": 1051, ""end_span"": 1054, ""type"": ""Disease/Disorder""}, {""token"": ""PHN"", ""start_span"": 1267, ""end_span"": 1270, ""type"": ""Disease/Disorder""}, {""token"": ""HZ"", ""start_span"": 1336, ""end_span"": 1338, ""type"": ""Disease/Disorder""}, {""token"": ""PHN"", ""start_span"": 1347, ""end_span"": 1350, ""type"": ""Disease/Disorder""}, {""token"": ""HZ"", ""start_span"": 1419, ""end_span"": 1421, ""type"": ""Disease/Disorder""}]"	test
The expression levels of some genes that encode ROS - scavenging enzymes, e. g ., cytosolic ascorbate peroxidase1 ( cAPX1 ), ascorbate peroxidase2 ( APX2 ), and Fe superoxide dismutase ( FSD1 ), increased in the P7 - 1 - OE anthers about 2 - fold higher than in wild - type, but the levels of ROS - producing related genes, e. g ., respiratory burst oxidase homolog A ( RBOHA) and respiratory burst oxidase homolog B ( RBOHB ), were reduced in the transgenic anthers compared with the wild type ( Figure 6C ).	cytosolic ascorbate peroxidase1,82,113,Gene/Protein	cAPX1,116,121,Gene/Protein	ascorbate peroxidase2,125,146,Gene/Protein	APX2,149,153,Gene/Protein	Fe superoxide dismutase,161,184,Gene/Protein	FSD1,187,191,Gene/Protein	P7 - 1,212,218,Gene/Protein	respiratory burst oxidase homolog A,332,367,Gene/Protein	RBOHA,370,375,Gene/Protein	respiratory burst oxidase homolog B,381,416,Gene/Protein	RBOHB,419,424,Gene/Protein	"[{""token"": ""cytosolic ascorbate peroxidase1"", ""start_span"": 82, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""cAPX1"", ""start_span"": 116, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""ascorbate peroxidase2"", ""start_span"": 125, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""APX2"", ""start_span"": 149, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""Fe superoxide dismutase"", ""start_span"": 161, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""FSD1"", ""start_span"": 187, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""P7 - 1"", ""start_span"": 212, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""respiratory burst oxidase homolog A"", ""start_span"": 332, ""end_span"": 367, ""type"": ""Gene/Protein""}, {""token"": ""RBOHA"", ""start_span"": 370, ""end_span"": 375, ""type"": ""Gene/Protein""}, {""token"": ""respiratory burst oxidase homolog B"", ""start_span"": 381, ""end_span"": 416, ""type"": ""Gene/Protein""}, {""token"": ""RBOHB"", ""start_span"": 419, ""end_span"": 424, ""type"": ""Gene/Protein""}]"	test
Here, we showed that the transcriptional levels of the lignin biosynthesis genes 4CL, CCoAOMT, and C3H were reduced in the flowers of RBSDV P7 - 1 transgenic plants compared with the flowers of wild - type plants ( Figure 5 ), although the expression levels of CCR1, CAD c, and CAD d were unchanged in the transgenic plants ( data not shown ).	4CL,81,84,Gene/Protein	CCoAOMT,86,93,Gene/Protein	C3H,99,102,Gene/Protein	RBSDV,134,139,Organism/Species	P7 - 1,140,146,Gene/Protein	plants,158,164,Organism/Species	plants,206,212,Organism/Species	CCR1,261,265,Gene/Protein	CAD c,267,272,Gene/Protein	CAD d,278,283,Gene/Protein	plants,317,323,Organism/Species	"[{""token"": ""4CL"", ""start_span"": 81, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""CCoAOMT"", ""start_span"": 86, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""C3H"", ""start_span"": 99, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""RBSDV"", ""start_span"": 134, ""end_span"": 139, ""type"": ""Organism/Species""}, {""token"": ""P7 - 1"", ""start_span"": 140, ""end_span"": 146, ""type"": ""Gene/Protein""}, {""token"": ""plants"", ""start_span"": 158, ""end_span"": 164, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 206, ""end_span"": 212, ""type"": ""Organism/Species""}, {""token"": ""CCR1"", ""start_span"": 261, ""end_span"": 265, ""type"": ""Gene/Protein""}, {""token"": ""CAD c"", ""start_span"": 267, ""end_span"": 272, ""type"": ""Gene/Protein""}, {""token"": ""CAD d"", ""start_span"": 278, ""end_span"": 283, ""type"": ""Gene/Protein""}, {""token"": ""plants"", ""start_span"": 317, ""end_span"": 323, ""type"": ""Organism/Species""}]"	test
Expression levels of 7 immune checkpoint molecules ( PD - 1, CTLA - 4, LAG - 3, TIGIT, TIM - 3, CD160 and 2B4) as well as 4 markers of HIV persistence ( integrated and total HIV DNA, 2 - LTR circles and cell - associated unspliced HIV RNA) were measured in PBMCs from 48 virally suppressed individuals.	immune checkpoint molecules,23,50,Gene/Protein	PD - 1,53,59,Gene/Protein	CTLA - 4,61,69,Gene/Protein	LAG - 3,71,78,Gene/Protein	TIGIT,80,85,Gene/Protein	TIM - 3,87,94,Gene/Protein	CD160,96,101,Gene/Protein	2B4,106,109,Gene/Protein	HIV,135,138,Organism/Species	HIV,174,177,Organism/Species	HIV,231,234,Organism/Species	"[{""token"": ""immune checkpoint molecules"", ""start_span"": 23, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""PD - 1"", ""start_span"": 53, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""CTLA - 4"", ""start_span"": 61, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""LAG - 3"", ""start_span"": 71, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""TIGIT"", ""start_span"": 80, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""TIM - 3"", ""start_span"": 87, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""CD160"", ""start_span"": 96, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""2B4"", ""start_span"": 106, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""HIV"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 174, ""end_span"": 177, ""type"": ""Organism/Species""}, {""token"": ""HIV"", ""start_span"": 231, ""end_span"": 234, ""type"": ""Organism/Species""}]"	test
The same antibody backbone was used in the two panels: CD3 - Alexa700 ( clone UCHT1, BD # 557943 ), CD4 - QDot605 ( clone S3. 5, Invitrogen # Q10008 ), CD8 - PB ( clone RPA - T8, BD # 558207 ), CD14 - V500 ( clone M5E2, BD # 561391 ), CD19 - AmCyan ( clone SJ25C1, BD # 339190 ), LIVE / DEAD Aqua marker ( Invitrogen # L34957 ), CD45RA - APC - H7 ( clone HI100, BD # 560674 ), CD27 - BV650 ( clone O323, Biolegend # 302828) and CCR7 - PE - Cy7 ( clone 3D12, BD # 557648 ).	antibody,9,17,Gene/Protein	CD3,55,58,Gene/Protein	CD4,100,103,Gene/Protein	Q10008,142,148,Chemical/Drug	CD8,152,155,Gene/Protein	CD14,194,198,Gene/Protein	CD19,235,239,Gene/Protein	CD45RA,329,335,Gene/Protein	CD27,377,381,Gene/Protein	CCR7,428,432,Gene/Protein	PE,435,437,Gene/Protein	"[{""token"": ""antibody"", ""start_span"": 9, ""end_span"": 17, ""type"": ""Gene/Protein""}, {""token"": ""CD3"", ""start_span"": 55, ""end_span"": 58, ""type"": ""Gene/Protein""}, {""token"": ""CD4"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Gene/Protein""}, {""token"": ""Q10008"", ""start_span"": 142, ""end_span"": 148, ""type"": ""Chemical/Drug""}, {""token"": ""CD8"", ""start_span"": 152, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""CD14"", ""start_span"": 194, ""end_span"": 198, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 235, ""end_span"": 239, ""type"": ""Gene/Protein""}, {""token"": ""CD45RA"", ""start_span"": 329, ""end_span"": 335, ""type"": ""Gene/Protein""}, {""token"": ""CD27"", ""start_span"": 377, ""end_span"": 381, ""type"": ""Gene/Protein""}, {""token"": ""CCR7"", ""start_span"": 428, ""end_span"": 432, ""type"": ""Gene/Protein""}, {""token"": ""PE"", ""start_span"": 435, ""end_span"": 437, ""type"": ""Gene/Protein""}]"	test
Primer sets were designed to differentiate and quantitate the following major anaerobic genera – Bacteroides, Clostridium, Campylobacter, Bifidobacterium, Ruminococcus, Eubacterium, Lactobacillus, Methanobrevibacter and Sulfate - reducing bacteria ( SRB ). 16S rRNA gene was targeted for designing primers except for SRB ( Table 1 ).	Bacteroides,97,108,Organism/Species	Clostridium,110,121,Organism/Species	Campylobacter,123,136,Organism/Species	Bifidobacterium,138,153,Organism/Species	Ruminococcus,155,167,Organism/Species	Eubacterium,169,180,Organism/Species	Lactobacillus,182,195,Organism/Species	Methanobrevibacter,197,215,Organism/Species	Sulfate - reducing bacteria,220,247,Organism/Species	SRB,250,253,Organism/Species	SRB,317,320,Organism/Species	"[{""token"": ""Bacteroides"", ""start_span"": 97, ""end_span"": 108, ""type"": ""Organism/Species""}, {""token"": ""Clostridium"", ""start_span"": 110, ""end_span"": 121, ""type"": ""Organism/Species""}, {""token"": ""Campylobacter"", ""start_span"": 123, ""end_span"": 136, ""type"": ""Organism/Species""}, {""token"": ""Bifidobacterium"", ""start_span"": 138, ""end_span"": 153, ""type"": ""Organism/Species""}, {""token"": ""Ruminococcus"", ""start_span"": 155, ""end_span"": 167, ""type"": ""Organism/Species""}, {""token"": ""Eubacterium"", ""start_span"": 169, ""end_span"": 180, ""type"": ""Organism/Species""}, {""token"": ""Lactobacillus"", ""start_span"": 182, ""end_span"": 195, ""type"": ""Organism/Species""}, {""token"": ""Methanobrevibacter"", ""start_span"": 197, ""end_span"": 215, ""type"": ""Organism/Species""}, {""token"": ""Sulfate - reducing bacteria"", ""start_span"": 220, ""end_span"": 247, ""type"": ""Organism/Species""}, {""token"": ""SRB"", ""start_span"": 250, ""end_span"": 253, ""type"": ""Organism/Species""}, {""token"": ""SRB"", ""start_span"": 317, ""end_span"": 320, ""type"": ""Organism/Species""}]"	test
High quality DNA isolated from E. histolytica positive stool sample was subjected to Real Time analysis to assess the predominant gut flora that included Bacteroides, Bifidobacterium, Eubacterium, Clostridium leptum subgroup, Clostridium coccoides subgroup, Lactobacillus and Ruminococcus. Two subdominant genera Methanobrevibacter smithii and Sulphur reducing bacteria ( SRB) were also quantified.	gut flora,130,139,Organism/Species	Bacteroides,154,165,Organism/Species	Bifidobacterium,167,182,Organism/Species	Eubacterium,184,195,Organism/Species	Clostridium leptum,197,215,Organism/Species	Clostridium coccoides,226,247,Organism/Species	Lactobacillus,258,271,Organism/Species	Ruminococcus,276,288,Organism/Species	Methanobrevibacter smithii,313,339,Organism/Species	Sulphur reducing bacteria,344,369,Organism/Species	SRB,372,375,Organism/Species	"[{""token"": ""gut flora"", ""start_span"": 130, ""end_span"": 139, ""type"": ""Organism/Species""}, {""token"": ""Bacteroides"", ""start_span"": 154, ""end_span"": 165, ""type"": ""Organism/Species""}, {""token"": ""Bifidobacterium"", ""start_span"": 167, ""end_span"": 182, ""type"": ""Organism/Species""}, {""token"": ""Eubacterium"", ""start_span"": 184, ""end_span"": 195, ""type"": ""Organism/Species""}, {""token"": ""Clostridium leptum"", ""start_span"": 197, ""end_span"": 215, ""type"": ""Organism/Species""}, {""token"": ""Clostridium coccoides"", ""start_span"": 226, ""end_span"": 247, ""type"": ""Organism/Species""}, {""token"": ""Lactobacillus"", ""start_span"": 258, ""end_span"": 271, ""type"": ""Organism/Species""}, {""token"": ""Ruminococcus"", ""start_span"": 276, ""end_span"": 288, ""type"": ""Organism/Species""}, {""token"": ""Methanobrevibacter smithii"", ""start_span"": 313, ""end_span"": 339, ""type"": ""Organism/Species""}, {""token"": ""Sulphur reducing bacteria"", ""start_span"": 344, ""end_span"": 369, ""type"": ""Organism/Species""}, {""token"": ""SRB"", ""start_span"": 372, ""end_span"": 375, ""type"": ""Organism/Species""}]"	test
Monoclonal rat anti - mouse antibodies against CD29, CD44, CD45, and CD11b were from BD Biosciences; and rabbit anti - mouse inducible nitric oxide synthase ( iNOS) and CD206 monoclonal antibodies were from Abcam.	rat,11,14,Organism/Species	mouse,22,27,Organism/Species	CD29,47,51,Gene/Protein	CD44,53,57,Gene/Protein	CD45,59,63,Gene/Protein	CD11b,69,74,Gene/Protein	rabbit,105,111,Organism/Species	mouse,119,124,Organism/Species	nitric oxide synthase,135,156,Gene/Protein	iNOS,159,163,Gene/Protein	CD206,169,174,Gene/Protein	"[{""token"": ""rat"", ""start_span"": 11, ""end_span"": 14, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 22, ""end_span"": 27, ""type"": ""Organism/Species""}, {""token"": ""CD29"", ""start_span"": 47, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""CD44"", ""start_span"": 53, ""end_span"": 57, ""type"": ""Gene/Protein""}, {""token"": ""CD45"", ""start_span"": 59, ""end_span"": 63, ""type"": ""Gene/Protein""}, {""token"": ""CD11b"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""rabbit"", ""start_span"": 105, ""end_span"": 111, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 119, ""end_span"": 124, ""type"": ""Organism/Species""}, {""token"": ""nitric oxide synthase"", ""start_span"": 135, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""iNOS"", ""start_span"": 159, ""end_span"": 163, ""type"": ""Gene/Protein""}, {""token"": ""CD206"", ""start_span"": 169, ""end_span"": 174, ""type"": ""Gene/Protein""}]"	test
The human breast carcinoma MDA - MB - 231 - FLUC cells, human HCC - LM3 - FLUC hepatoma cells, human U87MG - FLUC glioma cells and murine 4T1 - FLUC breast cancer cells were stably transfected with a lentiviral vector containing a firefly luciferase reporter gene were first selected in vitro, and then injected into immune - deficient or normal mice.	human,4,9,Organism/Species	breast carcinoma,10,26,Disease/Disorder	human,56,61,Organism/Species	hepatoma,79,87,Disease/Disorder	human,95,100,Organism/Species	glioma,114,120,Disease/Disorder	murine,131,137,Organism/Species	breast cancer,149,162,Disease/Disorder	firefly,231,238,Organism/Species	luciferase,239,249,Gene/Protein	mice,346,350,Organism/Species	"[{""token"": ""human"", ""start_span"": 4, ""end_span"": 9, ""type"": ""Organism/Species""}, {""token"": ""breast carcinoma"", ""start_span"": 10, ""end_span"": 26, ""type"": ""Disease/Disorder""}, {""token"": ""human"", ""start_span"": 56, ""end_span"": 61, ""type"": ""Organism/Species""}, {""token"": ""hepatoma"", ""start_span"": 79, ""end_span"": 87, ""type"": ""Disease/Disorder""}, {""token"": ""human"", ""start_span"": 95, ""end_span"": 100, ""type"": ""Organism/Species""}, {""token"": ""glioma"", ""start_span"": 114, ""end_span"": 120, ""type"": ""Disease/Disorder""}, {""token"": ""murine"", ""start_span"": 131, ""end_span"": 137, ""type"": ""Organism/Species""}, {""token"": ""breast cancer"", ""start_span"": 149, ""end_span"": 162, ""type"": ""Disease/Disorder""}, {""token"": ""firefly"", ""start_span"": 231, ""end_span"": 238, ""type"": ""Organism/Species""}, {""token"": ""luciferase"", ""start_span"": 239, ""end_span"": 249, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 346, ""end_span"": 350, ""type"": ""Organism/Species""}]"	test
The mimicry amino acid sequences were submitted to the OrthoMCL program61 using a total of nine isolates from different Plasmodium species: P. falciparum 3D7 ( PF3D7_0206500 ). P. berghei ANKA ( PBANKA_0304100 ), P. yoelli yoelli 17X ( PY17X_0304700 ), P. yoelli yoelli YM ( PMY_0305000 ), P. yoelli yoelli 17XNL ( PY00070 ), P. chabaudi chabaudi ( PCHAS_0306300 ), P. knowlesi strain H ( PKNH_0414500 ), P. vivax Sal - 1 ( PVX_003755) and P. cynomolgi strain B ( PCYB_042380 ), which were publicly available at this time.	amino acid,12,22,Chemical/Drug	Plasmodium,120,130,Organism/Species	PF3D7_0206500,160,173,Gene/Protein	PBANKA_0304100,195,209,Gene/Protein	PY17X_0304700,236,249,Gene/Protein	PMY_0305000,275,286,Gene/Protein	PY00070,315,322,Gene/Protein	PCHAS_0306300,349,362,Gene/Protein	PKNH_0414500,389,401,Gene/Protein	PVX_003755,424,434,Gene/Protein	PCYB_042380,464,475,Gene/Protein	"[{""token"": ""amino acid"", ""start_span"": 12, ""end_span"": 22, ""type"": ""Chemical/Drug""}, {""token"": ""Plasmodium"", ""start_span"": 120, ""end_span"": 130, ""type"": ""Organism/Species""}, {""token"": ""PF3D7_0206500"", ""start_span"": 160, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""PBANKA_0304100"", ""start_span"": 195, ""end_span"": 209, ""type"": ""Gene/Protein""}, {""token"": ""PY17X_0304700"", ""start_span"": 236, ""end_span"": 249, ""type"": ""Gene/Protein""}, {""token"": ""PMY_0305000"", ""start_span"": 275, ""end_span"": 286, ""type"": ""Gene/Protein""}, {""token"": ""PY00070"", ""start_span"": 315, ""end_span"": 322, ""type"": ""Gene/Protein""}, {""token"": ""PCHAS_0306300"", ""start_span"": 349, ""end_span"": 362, ""type"": ""Gene/Protein""}, {""token"": ""PKNH_0414500"", ""start_span"": 389, ""end_span"": 401, ""type"": ""Gene/Protein""}, {""token"": ""PVX_003755"", ""start_span"": 424, ""end_span"": 434, ""type"": ""Gene/Protein""}, {""token"": ""PCYB_042380"", ""start_span"": 464, ""end_span"": 475, ""type"": ""Gene/Protein""}]"	train
Circulating amylin was positively associated with CRP, IL - 6, BMI, waist circumference, blood pressure, fasting glucose, insulin, amylin / insulin ratio, HOMA - IR, LDL cholesterol and triglycerides, while negatively associated with HDL cholesterol ( all P < 0. 001 ).	amylin,12,18,Gene/Protein	CRP,50,53,Gene/Protein	IL - 6,55,61,Gene/Protein	glucose,113,120,Chemical/Drug	insulin,122,129,Gene/Protein	amylin,131,137,Gene/Protein	insulin,140,147,Gene/Protein	IR,162,164,Disease/Disorder	cholesterol,170,181,Chemical/Drug	triglycerides,186,199,Chemical/Drug	cholesterol,238,249,Chemical/Drug	"[{""token"": ""amylin"", ""start_span"": 12, ""end_span"": 18, ""type"": ""Gene/Protein""}, {""token"": ""CRP"", ""start_span"": 50, ""end_span"": 53, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 55, ""end_span"": 61, ""type"": ""Gene/Protein""}, {""token"": ""glucose"", ""start_span"": 113, ""end_span"": 120, ""type"": ""Chemical/Drug""}, {""token"": ""insulin"", ""start_span"": 122, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""amylin"", ""start_span"": 131, ""end_span"": 137, ""type"": ""Gene/Protein""}, {""token"": ""insulin"", ""start_span"": 140, ""end_span"": 147, ""type"": ""Gene/Protein""}, {""token"": ""IR"", ""start_span"": 162, ""end_span"": 164, ""type"": ""Disease/Disorder""}, {""token"": ""cholesterol"", ""start_span"": 170, ""end_span"": 181, ""type"": ""Chemical/Drug""}, {""token"": ""triglycerides"", ""start_span"": 186, ""end_span"": 199, ""type"": ""Chemical/Drug""}, {""token"": ""cholesterol"", ""start_span"": 238, ""end_span"": 249, ""type"": ""Chemical/Drug""}]"	train
It should be considered, nevertheless, that fusion proteins ( GFP - CP, CP - GFP, RFP - CP, CP - RFP) are used in this work; although the results are similar for all tagged versions of the CP, and it is not immediately obvious how a tag would lead to the observed virus - induced changes in the subnuclear localization of this protein, the fact that we are not imaging the untagged CP should be kept in mind.	GFP,62,65,Gene/Protein	CP,68,70,Gene/Protein	CP,72,74,Gene/Protein	GFP,77,80,Gene/Protein	RFP,82,85,Gene/Protein	CP,88,90,Gene/Protein	CP,92,94,Gene/Protein	RFP,97,100,Gene/Protein	CP,189,191,Gene/Protein	virus,264,269,Organism/Species	CP,382,384,Gene/Protein	"[{""token"": ""GFP"", ""start_span"": 62, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""CP"", ""start_span"": 68, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""CP"", ""start_span"": 72, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 77, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""RFP"", ""start_span"": 82, ""end_span"": 85, ""type"": ""Gene/Protein""}, {""token"": ""CP"", ""start_span"": 88, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""CP"", ""start_span"": 92, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""RFP"", ""start_span"": 97, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""CP"", ""start_span"": 189, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""virus"", ""start_span"": 264, ""end_span"": 269, ""type"": ""Organism/Species""}, {""token"": ""CP"", ""start_span"": 382, ""end_span"": 384, ""type"": ""Gene/Protein""}]"	train
Cells were analyzed for markers that can be used to identify distinct hematopoietic stem / progenitor cell populations including Lin ( CD4, CD8, B220, Ter - 119, Gr - 1, CD11b ), Sca - 1 ( D7 ), C - kit ( C2B8 ), CD150 ( mshad ), CD105 ( Mu7 / 18 ), and CD16 / 32 ( 93 ).	CD4,135,138,Gene/Protein	CD8,140,143,Gene/Protein	B220,145,149,Gene/Protein	Ter - 119,151,160,Gene/Protein	Gr - 1,162,168,Gene/Protein	CD11b,170,175,Gene/Protein	Sca - 1,179,186,Gene/Protein	C - kit,195,202,Gene/Protein	CD150,213,218,Gene/Protein	CD105,230,235,Gene/Protein	CD16,254,258,Gene/Protein	"[{""token"": ""CD4"", ""start_span"": 135, ""end_span"": 138, ""type"": ""Gene/Protein""}, {""token"": ""CD8"", ""start_span"": 140, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""B220"", ""start_span"": 145, ""end_span"": 149, ""type"": ""Gene/Protein""}, {""token"": ""Ter - 119"", ""start_span"": 151, ""end_span"": 160, ""type"": ""Gene/Protein""}, {""token"": ""Gr - 1"", ""start_span"": 162, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""CD11b"", ""start_span"": 170, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""Sca - 1"", ""start_span"": 179, ""end_span"": 186, ""type"": ""Gene/Protein""}, {""token"": ""C - kit"", ""start_span"": 195, ""end_span"": 202, ""type"": ""Gene/Protein""}, {""token"": ""CD150"", ""start_span"": 213, ""end_span"": 218, ""type"": ""Gene/Protein""}, {""token"": ""CD105"", ""start_span"": 230, ""end_span"": 235, ""type"": ""Gene/Protein""}, {""token"": ""CD16"", ""start_span"": 254, ""end_span"": 258, ""type"": ""Gene/Protein""}]"	train
Of note, we found up - regulation of multiple developmental genes ( e. g ., Bmp1, Mmp12 and kcnj8 ), transcription factors ( TFs) ( e. g ., Myc, Ap1, Stat3 and Cux1) and integrins ( e. g ., Itga1, 2b, a3, 5 and b11 ).	Bmp1,76,80,Gene/Protein	Mmp12,82,87,Gene/Protein	kcnj8,92,97,Gene/Protein	transcription factors,101,122,Gene/Protein	TFs,125,128,Gene/Protein	Myc,140,143,Gene/Protein	Ap1,145,148,Gene/Protein	Stat3,150,155,Gene/Protein	Cux1,160,164,Gene/Protein	integrins,170,179,Gene/Protein	Itga1,190,195,Gene/Protein	"[{""token"": ""Bmp1"", ""start_span"": 76, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""Mmp12"", ""start_span"": 82, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""kcnj8"", ""start_span"": 92, ""end_span"": 97, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 101, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""TFs"", ""start_span"": 125, ""end_span"": 128, ""type"": ""Gene/Protein""}, {""token"": ""Myc"", ""start_span"": 140, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""Ap1"", ""start_span"": 145, ""end_span"": 148, ""type"": ""Gene/Protein""}, {""token"": ""Stat3"", ""start_span"": 150, ""end_span"": 155, ""type"": ""Gene/Protein""}, {""token"": ""Cux1"", ""start_span"": 160, ""end_span"": 164, ""type"": ""Gene/Protein""}, {""token"": ""integrins"", ""start_span"": 170, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""Itga1"", ""start_span"": 190, ""end_span"": 195, ""type"": ""Gene/Protein""}]"	train
The ratio of differentially expressed genes ( SA1, SA2, SA3, SA4, SAA, SAB, SAC and SAD) expressed in a sample versus a calibrator ( healthy plant and plant infiltrated with pGreen0029) in comparison to a reference gene ( rubisco) is indicated in the Tables 2, 3 and 4.	SA1,46,49,Gene/Protein	SA2,51,54,Gene/Protein	SA3,56,59,Gene/Protein	SA4,61,64,Gene/Protein	SAA,66,69,Gene/Protein	SAB,71,74,Gene/Protein	SAC,76,79,Gene/Protein	SAD,84,87,Gene/Protein	plant,141,146,Organism/Species	plant,151,156,Organism/Species	rubisco,222,229,Gene/Protein	"[{""token"": ""SA1"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""SA2"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""SA3"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""SA4"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""SAA"", ""start_span"": 66, ""end_span"": 69, ""type"": ""Gene/Protein""}, {""token"": ""SAB"", ""start_span"": 71, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""SAC"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Gene/Protein""}, {""token"": ""SAD"", ""start_span"": 84, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""plant"", ""start_span"": 141, ""end_span"": 146, ""type"": ""Organism/Species""}, {""token"": ""plant"", ""start_span"": 151, ""end_span"": 156, ""type"": ""Organism/Species""}, {""token"": ""rubisco"", ""start_span"": 222, ""end_span"": 229, ""type"": ""Gene/Protein""}]"	train
It has been suggested that CRCK2 protein is up regulated ( Figure 2) during pathogen infection and also regulates the activities of a wide range of CaM binding proteins ( CaMBPs ), including metabolic enzymes, transcription factors such as WRKY group II d [ 44 ], ion channels, protein kinases / phosphatases and structural proteins [ 45, 46 ], as indicated in Figure 3.	CRCK2,27,32,Gene/Protein	infection,85,94,Disease/Disorder	CaM binding proteins,148,168,Gene/Protein	CaMBPs,171,177,Gene/Protein	metabolic enzymes,191,208,Gene/Protein	transcription factors,210,231,Gene/Protein	WRKY group II d,240,255,Gene/Protein	ion channels,264,276,Gene/Protein	protein kinases,278,293,Gene/Protein	phosphatases,296,308,Gene/Protein	structural proteins,313,332,Gene/Protein	"[{""token"": ""CRCK2"", ""start_span"": 27, ""end_span"": 32, ""type"": ""Gene/Protein""}, {""token"": ""infection"", ""start_span"": 85, ""end_span"": 94, ""type"": ""Disease/Disorder""}, {""token"": ""CaM binding proteins"", ""start_span"": 148, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""CaMBPs"", ""start_span"": 171, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""metabolic enzymes"", ""start_span"": 191, ""end_span"": 208, ""type"": ""Gene/Protein""}, {""token"": ""transcription factors"", ""start_span"": 210, ""end_span"": 231, ""type"": ""Gene/Protein""}, {""token"": ""WRKY group II d"", ""start_span"": 240, ""end_span"": 255, ""type"": ""Gene/Protein""}, {""token"": ""ion channels"", ""start_span"": 264, ""end_span"": 276, ""type"": ""Gene/Protein""}, {""token"": ""protein kinases"", ""start_span"": 278, ""end_span"": 293, ""type"": ""Gene/Protein""}, {""token"": ""phosphatases"", ""start_span"": 296, ""end_span"": 308, ""type"": ""Gene/Protein""}, {""token"": ""structural proteins"", ""start_span"": 313, ""end_span"": 332, ""type"": ""Gene/Protein""}]"	train
Treatment with UV - B increased the concentrations of kaempferol glycosides and specific glucosinolates in broccoli plants, and feeding on these plants reduced the fecundity of the specialist aphid Brevicoryne brassicae Linnaeus but improved the performance of the generalist aphid Myzus persicae Sulzer ( both Hemiptera: Aphididae) [ 6 ].	kaempferol glycosides,54,75,Chemical/Drug	glucosinolates,89,103,Chemical/Drug	broccoli,107,115,Organism/Species	plants,116,122,Organism/Species	plants,145,151,Organism/Species	aphid,192,197,Organism/Species	Brevicoryne brassicae Linnaeus,198,228,Organism/Species	aphid,276,281,Organism/Species	Myzus persicae,282,296,Organism/Species	Hemiptera,311,320,Organism/Species	Aphididae,322,331,Organism/Species	"[{""token"": ""kaempferol glycosides"", ""start_span"": 54, ""end_span"": 75, ""type"": ""Chemical/Drug""}, {""token"": ""glucosinolates"", ""start_span"": 89, ""end_span"": 103, ""type"": ""Chemical/Drug""}, {""token"": ""broccoli"", ""start_span"": 107, ""end_span"": 115, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 116, ""end_span"": 122, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 145, ""end_span"": 151, ""type"": ""Organism/Species""}, {""token"": ""aphid"", ""start_span"": 192, ""end_span"": 197, ""type"": ""Organism/Species""}, {""token"": ""Brevicoryne brassicae Linnaeus"", ""start_span"": 198, ""end_span"": 228, ""type"": ""Organism/Species""}, {""token"": ""aphid"", ""start_span"": 276, ""end_span"": 281, ""type"": ""Organism/Species""}, {""token"": ""Myzus persicae"", ""start_span"": 282, ""end_span"": 296, ""type"": ""Organism/Species""}, {""token"": ""Hemiptera"", ""start_span"": 311, ""end_span"": 320, ""type"": ""Organism/Species""}, {""token"": ""Aphididae"", ""start_span"": 322, ""end_span"": 331, ""type"": ""Organism/Species""}]"	train
Another interesting finding is that only the well characterized HSPs ( i. e ., HSP40 and HSP70) are expressed at the early time points, while the smaller HSPs and chaperonins ( HSPE1, HSP60; HSPE1, HSP10; HSPB2, HSP27) are expressed at roughly 24 h post - exposure.	HSPs,64,68,Gene/Protein	HSP40,79,84,Gene/Protein	HSP70,89,94,Gene/Protein	HSPs,154,158,Gene/Protein	chaperonins,163,174,Gene/Protein	HSPE1,177,182,Gene/Protein	HSP60,184,189,Gene/Protein	HSPE1,191,196,Gene/Protein	HSP10,198,203,Gene/Protein	HSPB2,205,210,Gene/Protein	HSP27,212,217,Gene/Protein	"[{""token"": ""HSPs"", ""start_span"": 64, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""HSP40"", ""start_span"": 79, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""HSP70"", ""start_span"": 89, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""HSPs"", ""start_span"": 154, ""end_span"": 158, ""type"": ""Gene/Protein""}, {""token"": ""chaperonins"", ""start_span"": 163, ""end_span"": 174, ""type"": ""Gene/Protein""}, {""token"": ""HSPE1"", ""start_span"": 177, ""end_span"": 182, ""type"": ""Gene/Protein""}, {""token"": ""HSP60"", ""start_span"": 184, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""HSPE1"", ""start_span"": 191, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""HSP10"", ""start_span"": 198, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""HSPB2"", ""start_span"": 205, ""end_span"": 210, ""type"": ""Gene/Protein""}, {""token"": ""HSP27"", ""start_span"": 212, ""end_span"": 217, ""type"": ""Gene/Protein""}]"	train
In addition to the known phenotypes in mice, new phenotypes presumably involving NMDA receptor dysfunction or memantine effects, such as nystagmus ( in frogs) [ 10 ], oculomotor apraxia ( in cats) [ 11, 12 ], dementia ( in humans) [ 13, 14 ], have been observed in human patients with GRID2 gene deletions [ 15, 16, 17, 18 ].	mice,39,43,Organism/Species	NMDA receptor,81,94,Gene/Protein	memantine,110,119,Chemical/Drug	nystagmus,137,146,Disease/Disorder	frogs,152,157,Organism/Species	oculomotor apraxia,167,185,Disease/Disorder	cats,191,195,Organism/Species	dementia,209,217,Disease/Disorder	humans,223,229,Organism/Species	human,265,270,Organism/Species	GRID2,285,290,Gene/Protein	"[{""token"": ""mice"", ""start_span"": 39, ""end_span"": 43, ""type"": ""Organism/Species""}, {""token"": ""NMDA receptor"", ""start_span"": 81, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""memantine"", ""start_span"": 110, ""end_span"": 119, ""type"": ""Chemical/Drug""}, {""token"": ""nystagmus"", ""start_span"": 137, ""end_span"": 146, ""type"": ""Disease/Disorder""}, {""token"": ""frogs"", ""start_span"": 152, ""end_span"": 157, ""type"": ""Organism/Species""}, {""token"": ""oculomotor apraxia"", ""start_span"": 167, ""end_span"": 185, ""type"": ""Disease/Disorder""}, {""token"": ""cats"", ""start_span"": 191, ""end_span"": 195, ""type"": ""Organism/Species""}, {""token"": ""dementia"", ""start_span"": 209, ""end_span"": 217, ""type"": ""Disease/Disorder""}, {""token"": ""humans"", ""start_span"": 223, ""end_span"": 229, ""type"": ""Organism/Species""}, {""token"": ""human"", ""start_span"": 265, ""end_span"": 270, ""type"": ""Organism/Species""}, {""token"": ""GRID2"", ""start_span"": 285, ""end_span"": 290, ""type"": ""Gene/Protein""}]"	train
Here, we describe the gene phylogeny and expression of three major subfamilies of NLRs in teleostei, which we designate NLR - A and NLR - B ( resembling mammalian NOD and NALP subfamilies respectively) and NLR - C, a large subfamily ( characterized with a NOD - 3 - like NACHT domain and an unusual C - terminal domain) that appears in all teleostei genomes, and is unique to bony fish.	NLRs,82,86,Gene/Protein	teleostei,90,99,Organism/Species	NLR - A,120,127,Gene/Protein	NLR - B,132,139,Gene/Protein	NOD,163,166,Gene/Protein	NALP,171,175,Gene/Protein	NLR - C,206,213,Gene/Protein	NOD - 3,256,263,Gene/Protein	NACHT,271,276,Gene/Protein	teleostei,340,349,Organism/Species	bony fish,376,385,Organism/Species	"[{""token"": ""NLRs"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""teleostei"", ""start_span"": 90, ""end_span"": 99, ""type"": ""Organism/Species""}, {""token"": ""NLR - A"", ""start_span"": 120, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""NLR - B"", ""start_span"": 132, ""end_span"": 139, ""type"": ""Gene/Protein""}, {""token"": ""NOD"", ""start_span"": 163, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""NALP"", ""start_span"": 171, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""NLR - C"", ""start_span"": 206, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""NOD - 3"", ""start_span"": 256, ""end_span"": 263, ""type"": ""Gene/Protein""}, {""token"": ""NACHT"", ""start_span"": 271, ""end_span"": 276, ""type"": ""Gene/Protein""}, {""token"": ""teleostei"", ""start_span"": 340, ""end_span"": 349, ""type"": ""Organism/Species""}, {""token"": ""bony fish"", ""start_span"": 376, ""end_span"": 385, ""type"": ""Organism/Species""}]"	train
Membranes were blocked with 5% non - fat dry milk in Tris - buffered saline with 0. 1% Tween ( TBST) for 2 h, then were incubated overnight with the corresponding antibodies at 4 ° C, followed by incubation with horseradish peroxidase - conjugated goat anti - mouse IgG ( W402B, Promega, Madison, WI, USA) or goat anti - rabbit IgG ( W401B, Promega ), or rabbit anti - Goat IgG ( Zymax, Life Technologies, Carlsbad, CA, USA) as appropriate, for 1 h at RT in TBST.	horseradish,212,223,Organism/Species	peroxidase,224,234,Gene/Protein	goat,248,252,Organism/Species	mouse,260,265,Organism/Species	IgG,266,269,Gene/Protein	goat,309,313,Organism/Species	rabbit,321,327,Organism/Species	IgG,328,331,Gene/Protein	rabbit,355,361,Organism/Species	Goat,369,373,Organism/Species	IgG,374,377,Gene/Protein	"[{""token"": ""horseradish"", ""start_span"": 212, ""end_span"": 223, ""type"": ""Organism/Species""}, {""token"": ""peroxidase"", ""start_span"": 224, ""end_span"": 234, ""type"": ""Gene/Protein""}, {""token"": ""goat"", ""start_span"": 248, ""end_span"": 252, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 260, ""end_span"": 265, ""type"": ""Organism/Species""}, {""token"": ""IgG"", ""start_span"": 266, ""end_span"": 269, ""type"": ""Gene/Protein""}, {""token"": ""goat"", ""start_span"": 309, ""end_span"": 313, ""type"": ""Organism/Species""}, {""token"": ""rabbit"", ""start_span"": 321, ""end_span"": 327, ""type"": ""Organism/Species""}, {""token"": ""IgG"", ""start_span"": 328, ""end_span"": 331, ""type"": ""Gene/Protein""}, {""token"": ""rabbit"", ""start_span"": 355, ""end_span"": 361, ""type"": ""Organism/Species""}, {""token"": ""Goat"", ""start_span"": 369, ""end_span"": 373, ""type"": ""Organism/Species""}, {""token"": ""IgG"", ""start_span"": 374, ""end_span"": 377, ""type"": ""Gene/Protein""}]"	train
The antibodies used were, anti - p65 ( 1: 1000, sc372, Santa Cruz Biotechnology CA, USA ), anti - RelB ( 1: 1000, sc28689, Santa Cruz Biotechnology ), anti - p50 ( 1: 1000, sc1190, Santa Cruz Biotechnology ), anti - p52 ( 1: 1000, 05 – 361, Millipore ), anti - p - ERK1 / 2 ( 1: 10000, Cell Signaling ), anti - αtubulin ( 1: 2000, sc53646, Santa Cruz Biotechnology ), anti - GAPDH ( 1: 5000, sc25778, Santa Cruz) and anti - Laminin A / C ( 1: 1000, 4777, Cell Signaling ).	p65,33,36,Gene/Protein	RelB,98,102,Gene/Protein	sc28689,114,121,Chemical/Drug	p50,158,161,Gene/Protein	p52,216,219,Gene/Protein	ERK1,265,269,Gene/Protein	αtubulin,311,319,Gene/Protein	sc53646,331,338,Chemical/Drug	GAPDH,375,380,Gene/Protein	sc25778,392,399,Chemical/Drug	Laminin,424,431,Gene/Protein	"[{""token"": ""p65"", ""start_span"": 33, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""RelB"", ""start_span"": 98, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""sc28689"", ""start_span"": 114, ""end_span"": 121, ""type"": ""Chemical/Drug""}, {""token"": ""p50"", ""start_span"": 158, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""p52"", ""start_span"": 216, ""end_span"": 219, ""type"": ""Gene/Protein""}, {""token"": ""ERK1"", ""start_span"": 265, ""end_span"": 269, ""type"": ""Gene/Protein""}, {""token"": ""\u03b1tubulin"", ""start_span"": 311, ""end_span"": 319, ""type"": ""Gene/Protein""}, {""token"": ""sc53646"", ""start_span"": 331, ""end_span"": 338, ""type"": ""Chemical/Drug""}, {""token"": ""GAPDH"", ""start_span"": 375, ""end_span"": 380, ""type"": ""Gene/Protein""}, {""token"": ""sc25778"", ""start_span"": 392, ""end_span"": 399, ""type"": ""Chemical/Drug""}, {""token"": ""Laminin"", ""start_span"": 424, ""end_span"": 431, ""type"": ""Gene/Protein""}]"	train
While we observed a similar percentage of pulmonary arterial hypertension ( PAH) per se in the PH - AF and PH - SR group ( 45. 7% vs. 50. 3 %, n. s .), idiopathic PAH was more frequent in those with AF ( PH - AF 34. 3% vs. PH - SR 20. 0 %, p < 0. 05 ), reflecting an AF prevalence of 43. 6% in this subpopulation.	pulmonary arterial hypertension,42,73,Disease/Disorder	PAH,76,79,Disease/Disorder	PH,95,97,Disease/Disorder	AF,100,102,Disease/Disorder	PH,107,109,Disease/Disorder	PAH,163,166,Disease/Disorder	AF,199,201,Disease/Disorder	PH,204,206,Disease/Disorder	AF,209,211,Disease/Disorder	PH,223,225,Disease/Disorder	AF,267,269,Disease/Disorder	"[{""token"": ""pulmonary arterial hypertension"", ""start_span"": 42, ""end_span"": 73, ""type"": ""Disease/Disorder""}, {""token"": ""PAH"", ""start_span"": 76, ""end_span"": 79, ""type"": ""Disease/Disorder""}, {""token"": ""PH"", ""start_span"": 95, ""end_span"": 97, ""type"": ""Disease/Disorder""}, {""token"": ""AF"", ""start_span"": 100, ""end_span"": 102, ""type"": ""Disease/Disorder""}, {""token"": ""PH"", ""start_span"": 107, ""end_span"": 109, ""type"": ""Disease/Disorder""}, {""token"": ""PAH"", ""start_span"": 163, ""end_span"": 166, ""type"": ""Disease/Disorder""}, {""token"": ""AF"", ""start_span"": 199, ""end_span"": 201, ""type"": ""Disease/Disorder""}, {""token"": ""PH"", ""start_span"": 204, ""end_span"": 206, ""type"": ""Disease/Disorder""}, {""token"": ""AF"", ""start_span"": 209, ""end_span"": 211, ""type"": ""Disease/Disorder""}, {""token"": ""PH"", ""start_span"": 223, ""end_span"": 225, ""type"": ""Disease/Disorder""}, {""token"": ""AF"", ""start_span"": 267, ""end_span"": 269, ""type"": ""Disease/Disorder""}]"	train
Retinopathy, either background ( BG) or proliferative ( PR ), was more frequent among patients with CKD and with each of its components, particularly among patients with albuminuria ( Table 1 ). Table 1Baseline clinical characteristics of whole population and divided by the occurrence of 5 - year renal outcome among 2, 656 patients with type 1 diabetes mellitus. AllCKDpeGFR < 60 mL / min / 1. 73 m2pAlbuminuriapPatientsNoYesNoYesNoYesn = 2656n = 2097n = 559n = 2541n = 115n = 2179n = 477Male sex1487 ( 56. 0 %) 1178 ( 56. 2 %) 309 ( 55. 3 %) 0. 2201437 ( 56. 6 %) 50 ( 43. 5 %) 0. 9791213 ( 55. 7 %) 274 ( 57. 4 %) 0. 158Age ( years) 44 ± 1443 ± 1348 ± 15 < 0. 00143 ± 1360 ± 13 < 0. 00143 ± 1346 ± 150. 024Known duration of diabetes ( years) 17 ± 1216 ± 1119 ± 12 < 0. 00116 ± 1123 ± 130. 01316 ± 1119 ± 12 < 0. 001BMI ( Kg / m2) 24. 4 ± 3. 424. 3 ± 3. 324. 6 ± 3. 70. 29524. 3 ± 3. 325. 3 ± 3. 90. 07124. 3 ± 3. 324. 5 ± 3. 80. 376Serum creatinine ( mg / dL) 0. 84 ± 0. 160. 84 ± 0. 160. 85 ± 0. 170. 3790. 84 ± 0. 160. 92 ± 0. 17 < 0. 0010. 84 ± 0. 160. 84 ± 0. 170. 351eGFR ( mL / min / 1. 73 m2) 99 ± 16100 ± 1695 ± 18 < 0. 001100 ± 1678 ± 14 < 0. 00199 ± 1698 ± 170. 611Serum uric acid ( mg / dL) 3. 8 ± 2. 23. 8 ± 2. 43. 9 ± 1. 20. 8903. 8 ± 2. 24. 0 ± 1. 40. 9553. 8 ± 2. 33. 9 ± 1. 20. 691SUA in the top gender - specific quintile275 ( 18. 8 %) 204 ( 17. 7 %) 71 ( 22. 8 %) 0. 521253 ( 18. 1 %) 22 ( 32. 4 %) 0. 494216 ( 18. 0 %) 59 ( 22. 5 %) 0. 302HbA1c (%) ( mmol / mol) 7. 7 ± 1. 3 ( 60 ± 9) 7. 6 ± 1. 3 ( 59 ± 9) 7. 9 ± 1. 4 ( 63 ± 8 )< 0. 0017. 6 ± 1. 3 ( 59 ± 9) 8. 1 ± 1. 5 ( 65 ± 7) 0. 0237. 6 ± 1. 3 ( 59 ± 9) 7. 9 ± 1. 5 ( 63 ± 7 )< 0. 001HbA1c ≥ 7% (≥ 53 mmol / mol) 1843 ( 69. 4 %) 1433 ( 68. 3 %) 410 ( 73. 3 %) 0. 1871754 ( 69. 0 %) 89 ( 77. 4 %) 0. 5501495 ( 68. 6 %) 348 ( 73. 0 %) 0. 189Total cholesterol ( mg / dL) 189 ± 34189 ± 34189 ± 350. 248189 ± 34194 ± 350. 591189 ± 34188 ± 350. 309Triglycerides ( mg / dL) 84 ± 5682 ± 5493 ± 640. 00184 ± 5791 ± 520. 70282 ± 5494 ± 66 < 0. 001Triglycerides ≥ 150 mg / dl191 ( 7. 2 %) 137 ( 6. 5 %) 54 ( 9. 7 %) 0. 015181 ( 7. 1 %) 10 ( 8. 7 %) 0. 867141 ( 6. 5 %) 50 ( 10. 5 %) 0. 001HDL ( mg / dL) 62 ± 1962 ± 1962 ± 180. 10162 ± 1965 ± 180. 43163 ± 1961 ± 180. 059HDL < 40 M < 50 F mg / dL294 ( 11. 1 %) 227 ( 10. 8 %) 67 ( 12. 0 %) 0. 229282 ( 11. 1 %) 12 ( 10. 4 %) 0. 896235 ( 10. 8 %) 59 ( 12. 4 %) 0. 205LDL ( mg / dL) 110 ± 31111 ± 31108 ± 310. 064110 ± 31111 ± 310. 949111 ± 31108 ± 310. 058LDL ≥ 100 mg / dL1650 ( 62. 1 %) 1320 ( 62. 9 %) 330 ( 59. 0 %) 0. 0641583 ( 62. 3 %) 67 ( 58. 3 %) 0. 4371367 ( 62. 7 %) 283 ( 59. 3 %) 0. 099Systolic BP ( mmHg) 125 ± 17124 ± 16129 ± 19 < 0. 001125 ± 17137 ± 18 < 0. 001125 ± 17128 ± 180. 001Diastolic BP ( mmHg) 76 ± 975 ± 976 ± 90. 02476 ± 978 ± 90. 03576 ± 976 ± 90. 071Blood Pressure ≥ 140 / 85 mmHg779 ( 29. 3 %) 569 ( 27. 1 %) 210 ( 37. 6 %)< 0. 001716 ( 28. 2 %) 63 ( 54. 8 %)< 0. 001610 ( 28. 0 %) 169 ( 35. 4 %) 0. 002 Retinopathy Non - proliferative495 ( 18. 6 %) 363 ( 17. 3 %) 132 ( 23. 6 %) 0. 008468 ( 18. 4 %) 27 ( 23. 5 %) 0. 347384 ( 17. 6 %) 111 ( 23. 3 %) 0. 024 Proliferative152 ( 5. 7 %) 102 ( 4. 9 %) 50 ( 8. 9 %)< 0. 001138 ( 5. 4 %) 14 ( 12. 2 %) 0. 062110 ( 5. 0 %) 42 ( 8. 8 %)< 0. 001Smokers357 ( 26. 2 %) 271 ( 25. 0 %) 86 ( 31. 0 %) 0. 004349 ( 26. 8 %) 8 ( 13. 6 %) 0. 207278 ( 24. 6 %) 79 ( 34. 2 %) 0. 001Lipid - lowering treatment416 ( 15. 7 %) 295 ( 14. 1 %) 121 ( 21. 6 %) 0. 001385 ( 15. 2 %) 31 ( 27. 0 %) 0. 168314 ( 14. 4 %) 102 ( 21. 4 %) 0. 001Treatment with statins400 ( 15. 1 %) 281 ( 13. 4 %) 119 ( 21. 3 %)< 0. 001369 ( 14. 5 %) 31 ( 27. 0 %) 0. 073300 ( 13. 8 %) 100 ( 21. 0 %)< 0. 001Treatment with fibrates9 ( 0. 3 %) 8 ( 0. 4 %) 1 ( 0. 2 %) 0. 3669 ( 0. 4 %) 0 ( 0. 0 %) 1. 0008 ( 0. 4 %) 1 ( 0. 2 %) 0. 614Antihypertensive treatment534 ( 20. 1 %) 357 ( 17. 0 %) 177 ( 31. 7 %)< 0. 001480 ( 18. 9 %) 54 ( 47. 0 %)< 0. 001390 ( 17. 9 %) 144 ( 30. 2 %)< 0. 001Treatment with ACE - Is / ARBs484 ( 18. 2 %) 324 ( 15. 5 %) 160 ( 28. 6 %)< 0. 001434 ( 17. 1 %) 50 ( 43. 5 %)< 0. 001355 ( 16. 3 %) 129 ( 27. 0 %)< 0. 001Aspirin184 ( 6. 9 %) 128 ( 6. 1 %) 56 ( 10 %) 0. 024165 ( 6. 5 %) 19 ( 16. 5 %) 0. 141140 ( 6. 4 %) 44 ( 9. 2 %) 0. 026Insulin pump162 ( 6. 1 %) 132 ( 6. 3 %) 30 ( 5. 4 %) 0. 564155 ( 6. 1 %) 7 ( 6. 1 %) 0. 420139 ( 6. 4 %) 23 ( 4. 8 %) 0. 238Mean ± SD or absolute frequency ( percentage ).	Retinopathy,0,11,Disease/Disorder	CKD,100,103,Disease/Disorder	type 1 diabetes mellitus,339,363,Disease/Disorder	diabetes,728,736,Disease/Disorder	creatinine,942,952,Chemical/Drug	uric acid,1185,1194,Chemical/Drug	cholesterol,1823,1834,Chemical/Drug	Retinopathy,2951,2962,Disease/Disorder	statins400,3523,3533,Chemical/Drug	fibrates9,3669,3678,Chemical/Drug	ACE,3945,3948,Gene/Protein	"[{""token"": ""Retinopathy"", ""start_span"": 0, ""end_span"": 11, ""type"": ""Disease/Disorder""}, {""token"": ""CKD"", ""start_span"": 100, ""end_span"": 103, ""type"": ""Disease/Disorder""}, {""token"": ""type 1 diabetes mellitus"", ""start_span"": 339, ""end_span"": 363, ""type"": ""Disease/Disorder""}, {""token"": ""diabetes"", ""start_span"": 728, ""end_span"": 736, ""type"": ""Disease/Disorder""}, {""token"": ""creatinine"", ""start_span"": 942, ""end_span"": 952, ""type"": ""Chemical/Drug""}, {""token"": ""uric acid"", ""start_span"": 1185, ""end_span"": 1194, ""type"": ""Chemical/Drug""}, {""token"": ""cholesterol"", ""start_span"": 1823, ""end_span"": 1834, ""type"": ""Chemical/Drug""}, {""token"": ""Retinopathy"", ""start_span"": 2951, ""end_span"": 2962, ""type"": ""Disease/Disorder""}, {""token"": ""statins400"", ""start_span"": 3523, ""end_span"": 3533, ""type"": ""Chemical/Drug""}, {""token"": ""fibrates9"", ""start_span"": 3669, ""end_span"": 3678, ""type"": ""Chemical/Drug""}, {""token"": ""ACE"", ""start_span"": 3945, ""end_span"": 3948, ""type"": ""Gene/Protein""}]"	train
( A ). serous papillary adenocarcinoma ( stage I ); ( B ). serous papillary adenocarcinoma ( stage IIIA ); ( C ). serous papillary adenocarcinoma ( stage IIIC ); ( D ). mucinous adenocarcinoma mucinous adenocarcinoma ( stage IA ); ( E ). mucinous adenocarcinoma mucinous adenocarcinoma ( stage IB); ( F ). mucinous adenocarcinoma mucinous adenocarcinoma ( stage III ); ( G ). endometrioid adenocarcinoma ( stage I ); ( H ). endometrioid adenocarcinoma ( stage III ); ( I ). normal ovarian tissue.	serous papillary adenocarcinoma,7,38,Disease/Disorder	serous papillary adenocarcinoma,59,90,Disease/Disorder	serous papillary adenocarcinoma,114,145,Disease/Disorder	mucinous adenocarcinoma,169,192,Disease/Disorder	mucinous adenocarcinoma,193,216,Disease/Disorder	mucinous adenocarcinoma,238,261,Disease/Disorder	mucinous adenocarcinoma,262,285,Disease/Disorder	mucinous adenocarcinoma,306,329,Disease/Disorder	mucinous adenocarcinoma,330,353,Disease/Disorder	endometrioid adenocarcinoma,376,403,Disease/Disorder	endometrioid adenocarcinoma,424,451,Disease/Disorder	"[{""token"": ""serous papillary adenocarcinoma"", ""start_span"": 7, ""end_span"": 38, ""type"": ""Disease/Disorder""}, {""token"": ""serous papillary adenocarcinoma"", ""start_span"": 59, ""end_span"": 90, ""type"": ""Disease/Disorder""}, {""token"": ""serous papillary adenocarcinoma"", ""start_span"": 114, ""end_span"": 145, ""type"": ""Disease/Disorder""}, {""token"": ""mucinous adenocarcinoma"", ""start_span"": 169, ""end_span"": 192, ""type"": ""Disease/Disorder""}, {""token"": ""mucinous adenocarcinoma"", ""start_span"": 193, ""end_span"": 216, ""type"": ""Disease/Disorder""}, {""token"": ""mucinous adenocarcinoma"", ""start_span"": 238, ""end_span"": 261, ""type"": ""Disease/Disorder""}, {""token"": ""mucinous adenocarcinoma"", ""start_span"": 262, ""end_span"": 285, ""type"": ""Disease/Disorder""}, {""token"": ""mucinous adenocarcinoma"", ""start_span"": 306, ""end_span"": 329, ""type"": ""Disease/Disorder""}, {""token"": ""mucinous adenocarcinoma"", ""start_span"": 330, ""end_span"": 353, ""type"": ""Disease/Disorder""}, {""token"": ""endometrioid adenocarcinoma"", ""start_span"": 376, ""end_span"": 403, ""type"": ""Disease/Disorder""}, {""token"": ""endometrioid adenocarcinoma"", ""start_span"": 424, ""end_span"": 451, ""type"": ""Disease/Disorder""}]"	train
( A) The expression of MARCH7 protein level in SKOV3 cells was regulated by TGF - β1, TNF - α, IL - 1β, PTDC, NFkB P50 and NFkB P65 .( B) The protein expression level in SKOV3 and A2780 cells of NFkB P65, NFkB P50, E - cadherin and β - catenin was detected by western blot.	MARCH7,23,29,Gene/Protein	TGF - β1,76,84,Gene/Protein	TNF - α,86,93,Gene/Protein	IL - 1β,95,102,Gene/Protein	PTDC,104,108,Gene/Protein	NFkB P50,110,118,Gene/Protein	NFkB P65,123,131,Gene/Protein	NFkB P65,195,203,Gene/Protein	NFkB P50,205,213,Gene/Protein	E - cadherin,215,227,Gene/Protein	β - catenin,232,243,Gene/Protein	"[{""token"": ""MARCH7"", ""start_span"": 23, ""end_span"": 29, ""type"": ""Gene/Protein""}, {""token"": ""TGF - \u03b21"", ""start_span"": 76, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""TNF - \u03b1"", ""start_span"": 86, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1\u03b2"", ""start_span"": 95, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""PTDC"", ""start_span"": 104, ""end_span"": 108, ""type"": ""Gene/Protein""}, {""token"": ""NFkB P50"", ""start_span"": 110, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""NFkB P65"", ""start_span"": 123, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""NFkB P65"", ""start_span"": 195, ""end_span"": 203, ""type"": ""Gene/Protein""}, {""token"": ""NFkB P50"", ""start_span"": 205, ""end_span"": 213, ""type"": ""Gene/Protein""}, {""token"": ""E - cadherin"", ""start_span"": 215, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""\u03b2 - catenin"", ""start_span"": 232, ""end_span"": 243, ""type"": ""Gene/Protein""}]"	train
All patients who developed AEs were treated with corticosteroids, including methylprednisolone pulse therapy, and received no further chemotherapy. Table 6Outcomes of ten patients with acute exacerbations of ILDNo. Classification of ILDAssociated regimens ( chemotherapeutic line) Cycles receivedOnset of AE ( days from chemotherapy) Outcome of AESurvival ( days from onset of AE) 1Possible UIPPemetrexed ( second) 113Died162Inconsistent with UIPS - 1 ( third) 126Died23Possible UIPCarboplatin and docetaxel ( first) 5150Died364IPFCarboplatin and docetaxel ( first) 115Died125IPFCarboplatin and pemetrexed ( first) 241Recovered816IPFCarboplatin and docetaxel ( first) 322Died47IPFDocetaxel ( first) 252Recovered808IPFDocetaxel ( first) 246Died49Possible UIPDocetaxel ( second) 228Recovered38510IPFDocetaxel ( first) 118Recovered108 ILD interstitial lung disease, UIP usual interstitial pneumonia, IPF idiopathic pulmonary fibrosis, AE acute exacerbation	corticosteroids,49,64,Chemical/Drug	docetaxel,498,507,Chemical/Drug	docetaxel,547,556,Chemical/Drug	pemetrexed,595,605,Chemical/Drug	docetaxel,649,658,Chemical/Drug	ILD,832,835,Disease/Disorder	interstitial lung disease,836,861,Disease/Disorder	UIP,863,866,Disease/Disorder	usual interstitial pneumonia,867,895,Disease/Disorder	IPF,897,900,Disease/Disorder	idiopathic pulmonary fibrosis,901,930,Disease/Disorder	"[{""token"": ""corticosteroids"", ""start_span"": 49, ""end_span"": 64, ""type"": ""Chemical/Drug""}, {""token"": ""docetaxel"", ""start_span"": 498, ""end_span"": 507, ""type"": ""Chemical/Drug""}, {""token"": ""docetaxel"", ""start_span"": 547, ""end_span"": 556, ""type"": ""Chemical/Drug""}, {""token"": ""pemetrexed"", ""start_span"": 595, ""end_span"": 605, ""type"": ""Chemical/Drug""}, {""token"": ""docetaxel"", ""start_span"": 649, ""end_span"": 658, ""type"": ""Chemical/Drug""}, {""token"": ""ILD"", ""start_span"": 832, ""end_span"": 835, ""type"": ""Disease/Disorder""}, {""token"": ""interstitial lung disease"", ""start_span"": 836, ""end_span"": 861, ""type"": ""Disease/Disorder""}, {""token"": ""UIP"", ""start_span"": 863, ""end_span"": 866, ""type"": ""Disease/Disorder""}, {""token"": ""usual interstitial pneumonia"", ""start_span"": 867, ""end_span"": 895, ""type"": ""Disease/Disorder""}, {""token"": ""IPF"", ""start_span"": 897, ""end_span"": 900, ""type"": ""Disease/Disorder""}, {""token"": ""idiopathic pulmonary fibrosis"", ""start_span"": 901, ""end_span"": 930, ""type"": ""Disease/Disorder""}]"	train
SDS - PAGE was performed as described. 15, 29 The following antibodies were used: rabbit anti - β1 ( 1: 100; Abgent ), mouse anti - fyn ( 1: 1, 000; BioLegend ), mouse anti - CD44 ( 1: 1, 000; AbD Serotec ); rabbit anti - E - cadherin ( 1: 1, 000; Cell Signaling Technology ); mouse anti - β - actin ( 1: 30, 000; Proteintech ); and mouse anti - α - tubulin ( 1: 10, 000; Sigma ).	rabbit,82,88,Organism/Species	mouse,119,124,Organism/Species	fyn,132,135,Gene/Protein	mouse,162,167,Organism/Species	CD44,175,179,Gene/Protein	rabbit,208,214,Organism/Species	E - cadherin,222,234,Gene/Protein	mouse,277,282,Organism/Species	β - actin,290,299,Gene/Protein	mouse,333,338,Organism/Species	α - tubulin,346,357,Gene/Protein	"[{""token"": ""rabbit"", ""start_span"": 82, ""end_span"": 88, ""type"": ""Organism/Species""}, {""token"": ""mouse"", ""start_span"": 119, ""end_span"": 124, ""type"": ""Organism/Species""}, {""token"": ""fyn"", ""start_span"": 132, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 162, ""end_span"": 167, ""type"": ""Organism/Species""}, {""token"": ""CD44"", ""start_span"": 175, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""rabbit"", ""start_span"": 208, ""end_span"": 214, ""type"": ""Organism/Species""}, {""token"": ""E - cadherin"", ""start_span"": 222, ""end_span"": 234, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 277, ""end_span"": 282, ""type"": ""Organism/Species""}, {""token"": ""\u03b2 - actin"", ""start_span"": 290, ""end_span"": 299, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 333, ""end_span"": 338, ""type"": ""Organism/Species""}, {""token"": ""\u03b1 - tubulin"", ""start_span"": 346, ""end_span"": 357, ""type"": ""Gene/Protein""}]"	train
Reverse transcription - polymerase chain reaction ( RT - PCR) assay using the pull - downs was performed to detect pcr1 + and other ATF / CREB factors, atf1 +, atf21 +, and atf31 + mRNA. ( C) pcr1 + RNA complexes with Spo5C more efficiently than atf21 + RNA does. atf21 + RNA carried the coding region and both 5 ′- and 3 ′- UTRs, similarly to pcr1 + RNA.	polymerase,24,34,Gene/Protein	pcr1,115,119,Gene/Protein	ATF,132,135,Gene/Protein	CREB,138,142,Gene/Protein	atf1,152,156,Gene/Protein	atf21,160,165,Gene/Protein	atf31,173,178,Gene/Protein	pcr1,192,196,Gene/Protein	atf21,246,251,Gene/Protein	atf21,264,269,Gene/Protein	pcr1,344,348,Gene/Protein	"[{""token"": ""polymerase"", ""start_span"": 24, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""pcr1"", ""start_span"": 115, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""ATF"", ""start_span"": 132, ""end_span"": 135, ""type"": ""Gene/Protein""}, {""token"": ""CREB"", ""start_span"": 138, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""atf1"", ""start_span"": 152, ""end_span"": 156, ""type"": ""Gene/Protein""}, {""token"": ""atf21"", ""start_span"": 160, ""end_span"": 165, ""type"": ""Gene/Protein""}, {""token"": ""atf31"", ""start_span"": 173, ""end_span"": 178, ""type"": ""Gene/Protein""}, {""token"": ""pcr1"", ""start_span"": 192, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""atf21"", ""start_span"": 246, ""end_span"": 251, ""type"": ""Gene/Protein""}, {""token"": ""atf21"", ""start_span"": 264, ""end_span"": 269, ""type"": ""Gene/Protein""}, {""token"": ""pcr1"", ""start_span"": 344, ""end_span"": 348, ""type"": ""Gene/Protein""}]"	train
h 90 spo5 ( RRM1 ∆, ∆ 297 - 366 )- GFP - kan cut11 - 4mRFP - hph CFP - atb2 - nat ade6 - M216 leu1 ura4	spo5,5,9,Gene/Protein	RRM1,12,16,Gene/Protein	GFP,35,38,Gene/Protein	cut11,45,50,Gene/Protein	hph,61,64,Gene/Protein	CFP,65,68,Gene/Protein	atb2,71,75,Gene/Protein	nat,78,81,Gene/Protein	ade6,82,86,Gene/Protein	leu1,94,98,Gene/Protein	ura4,99,103,Gene/Protein	"[{""token"": ""spo5"", ""start_span"": 5, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""RRM1"", ""start_span"": 12, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""cut11"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""hph"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""CFP"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""atb2"", ""start_span"": 71, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""nat"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""ade6"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""leu1"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""ura4"", ""start_span"": 99, ""end_span"": 103, ""type"": ""Gene/Protein""}]"	train
h 90 spo5 ( RRM2 ∆, ∆ 385 - 456 )- GFP - kan cut11 - 4mRFP - hph CFP - atb2 - nat ade6 - M216 leu1 ura4	spo5,5,9,Gene/Protein	RRM2,12,16,Gene/Protein	GFP,35,38,Gene/Protein	cut11,45,50,Gene/Protein	hph,61,64,Gene/Protein	CFP,65,68,Gene/Protein	atb2,71,75,Gene/Protein	nat,78,81,Gene/Protein	ade6,82,86,Gene/Protein	leu1,94,98,Gene/Protein	ura4,99,103,Gene/Protein	"[{""token"": ""spo5"", ""start_span"": 5, ""end_span"": 9, ""type"": ""Gene/Protein""}, {""token"": ""RRM2"", ""start_span"": 12, ""end_span"": 16, ""type"": ""Gene/Protein""}, {""token"": ""GFP"", ""start_span"": 35, ""end_span"": 38, ""type"": ""Gene/Protein""}, {""token"": ""cut11"", ""start_span"": 45, ""end_span"": 50, ""type"": ""Gene/Protein""}, {""token"": ""hph"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""CFP"", ""start_span"": 65, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""atb2"", ""start_span"": 71, ""end_span"": 75, ""type"": ""Gene/Protein""}, {""token"": ""nat"", ""start_span"": 78, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""ade6"", ""start_span"": 82, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""leu1"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""ura4"", ""start_span"": 99, ""end_span"": 103, ""type"": ""Gene/Protein""}]"	train
The homogenate was centrifuged at 12 000 rpm for 10 min at 4 ° C and the resultant supernatant was collected for assays of proline, H2O2, and antioxidant enzymes, namely superoxide dismutase ( SOD; EC 1. 15. 1. 1 ), catalase ( CAT; EC 1. 11. 1. 6 ), and peroxidase ( POD; EC 1. 11. 1. 7 ), using relevant detection kits ( A107 for proline, A064 - 1 for H2O2, A084 - 3 for POD, A001 - 1 for SOD, and A007 - 1 for CAT, Nanjing Jiancheng Bioengineering Institute, Jiangsu, China) following the manufacturer ’ s instructions.	proline,123,130,Chemical/Drug	superoxide dismutase,170,190,Gene/Protein	SOD,193,196,Gene/Protein	catalase,216,224,Gene/Protein	CAT,227,230,Gene/Protein	peroxidase,254,264,Gene/Protein	POD,267,270,Gene/Protein	proline,331,338,Chemical/Drug	POD,372,375,Gene/Protein	SOD,390,393,Gene/Protein	CAT,412,415,Gene/Protein	"[{""token"": ""proline"", ""start_span"": 123, ""end_span"": 130, ""type"": ""Chemical/Drug""}, {""token"": ""superoxide dismutase"", ""start_span"": 170, ""end_span"": 190, ""type"": ""Gene/Protein""}, {""token"": ""SOD"", ""start_span"": 193, ""end_span"": 196, ""type"": ""Gene/Protein""}, {""token"": ""catalase"", ""start_span"": 216, ""end_span"": 224, ""type"": ""Gene/Protein""}, {""token"": ""CAT"", ""start_span"": 227, ""end_span"": 230, ""type"": ""Gene/Protein""}, {""token"": ""peroxidase"", ""start_span"": 254, ""end_span"": 264, ""type"": ""Gene/Protein""}, {""token"": ""POD"", ""start_span"": 267, ""end_span"": 270, ""type"": ""Gene/Protein""}, {""token"": ""proline"", ""start_span"": 331, ""end_span"": 338, ""type"": ""Chemical/Drug""}, {""token"": ""POD"", ""start_span"": 372, ""end_span"": 375, ""type"": ""Gene/Protein""}, {""token"": ""SOD"", ""start_span"": 390, ""end_span"": 393, ""type"": ""Gene/Protein""}, {""token"": ""CAT"", ""start_span"": 412, ""end_span"": 415, ""type"": ""Gene/Protein""}]"	train
Quantitative real - time RT - PCR was carried out to examine the relative expression levels of nine CsbHLH genes ( CsbHLH2, CsbHLH4, CsbHLH18, CsbHLH22, CsbHLH26, CsbHLH34, CsbHLH36, CsbHLH41, and CsbHLH46) in response to cold stress. Actin was used as an internal control.	CsbHLH,100,106,Gene/Protein	CsbHLH2,115,122,Gene/Protein	CsbHLH4,124,131,Gene/Protein	CsbHLH18,133,141,Gene/Protein	CsbHLH22,143,151,Gene/Protein	CsbHLH26,153,161,Gene/Protein	CsbHLH34,163,171,Gene/Protein	CsbHLH36,173,181,Gene/Protein	CsbHLH41,183,191,Gene/Protein	CsbHLH46,197,205,Gene/Protein	Actin,235,240,Gene/Protein	"[{""token"": ""CsbHLH"", ""start_span"": 100, ""end_span"": 106, ""type"": ""Gene/Protein""}, {""token"": ""CsbHLH2"", ""start_span"": 115, ""end_span"": 122, ""type"": ""Gene/Protein""}, {""token"": ""CsbHLH4"", ""start_span"": 124, ""end_span"": 131, ""type"": ""Gene/Protein""}, {""token"": ""CsbHLH18"", ""start_span"": 133, ""end_span"": 141, ""type"": ""Gene/Protein""}, {""token"": ""CsbHLH22"", ""start_span"": 143, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""CsbHLH26"", ""start_span"": 153, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""CsbHLH34"", ""start_span"": 163, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""CsbHLH36"", ""start_span"": 173, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""CsbHLH41"", ""start_span"": 183, ""end_span"": 191, ""type"": ""Gene/Protein""}, {""token"": ""CsbHLH46"", ""start_span"": 197, ""end_span"": 205, ""type"": ""Gene/Protein""}, {""token"": ""Actin"", ""start_span"": 235, ""end_span"": 240, ""type"": ""Gene/Protein""}]"	train
However, the numbers of CD5 + CD1d + CD19 +, CD5 + CD1d + IL - 10 + CD19 +, and IL - 10 + CD19 + B cells per microliter of blood and the serum IL - 10 concentration were significantly increased in HSPN patients following treatment.	CD5,24,27,Gene/Protein	CD1d,30,34,Gene/Protein	CD19,37,41,Gene/Protein	CD5,45,48,Gene/Protein	CD1d,51,55,Gene/Protein	IL - 10,58,65,Gene/Protein	CD19,68,72,Gene/Protein	IL - 10,80,87,Gene/Protein	CD19,90,94,Gene/Protein	IL - 10,143,150,Gene/Protein	HSPN,197,201,Disease/Disorder	"[{""token"": ""CD5"", ""start_span"": 24, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""CD1d"", ""start_span"": 30, ""end_span"": 34, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 37, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""CD5"", ""start_span"": 45, ""end_span"": 48, ""type"": ""Gene/Protein""}, {""token"": ""CD1d"", ""start_span"": 51, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 58, ""end_span"": 65, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 68, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 80, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 90, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 143, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""HSPN"", ""start_span"": 197, ""end_span"": 201, ""type"": ""Disease/Disorder""}]"	train
However, there were increases in the numbers of IL - 10 + CD19 +, CD1d + CD5 + CD19 +, and IL - 10 + CD1d + CD5 + CD19 + B cells and the serum IL - 10 concentration in HSPN patients following treatment.	IL - 10,48,55,Gene/Protein	CD19,58,62,Gene/Protein	CD1d,66,70,Gene/Protein	CD5,73,76,Gene/Protein	CD19,79,83,Gene/Protein	IL - 10,91,98,Gene/Protein	CD1d,101,105,Gene/Protein	CD5,108,111,Gene/Protein	CD19,114,118,Gene/Protein	IL - 10,143,150,Gene/Protein	HSPN,168,172,Disease/Disorder	"[{""token"": ""IL - 10"", ""start_span"": 48, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""CD1d"", ""start_span"": 66, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""CD5"", ""start_span"": 73, ""end_span"": 76, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 79, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 91, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""CD1d"", ""start_span"": 101, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""CD5"", ""start_span"": 108, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""CD19"", ""start_span"": 114, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 143, ""end_span"": 150, ""type"": ""Gene/Protein""}, {""token"": ""HSPN"", ""start_span"": 168, ""end_span"": 172, ""type"": ""Disease/Disorder""}]"	train
Most of the down - regulated genes in the rural Indians ( that is, high Ct counts and hence lower expression) are annotated to anti - viral response ( SERPING1, DDX24, OAS3, MX1, OASL, IRF1) or inflammation / neutrophil signaling ( IKBKB, IRAK1, AKT1, ZDHHC18, NUP214 ), implying a generally lower immune response.	SERPING1,151,159,Gene/Protein	DDX24,161,166,Gene/Protein	OAS3,168,172,Gene/Protein	MX1,174,177,Gene/Protein	OASL,179,183,Gene/Protein	IRF1,185,189,Gene/Protein	IKBKB,232,237,Gene/Protein	IRAK1,239,244,Gene/Protein	AKT1,246,250,Gene/Protein	ZDHHC18,252,259,Gene/Protein	NUP214,261,267,Gene/Protein	"[{""token"": ""SERPING1"", ""start_span"": 151, ""end_span"": 159, ""type"": ""Gene/Protein""}, {""token"": ""DDX24"", ""start_span"": 161, ""end_span"": 166, ""type"": ""Gene/Protein""}, {""token"": ""OAS3"", ""start_span"": 168, ""end_span"": 172, ""type"": ""Gene/Protein""}, {""token"": ""MX1"", ""start_span"": 174, ""end_span"": 177, ""type"": ""Gene/Protein""}, {""token"": ""OASL"", ""start_span"": 179, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""IRF1"", ""start_span"": 185, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""IKBKB"", ""start_span"": 232, ""end_span"": 237, ""type"": ""Gene/Protein""}, {""token"": ""IRAK1"", ""start_span"": 239, ""end_span"": 244, ""type"": ""Gene/Protein""}, {""token"": ""AKT1"", ""start_span"": 246, ""end_span"": 250, ""type"": ""Gene/Protein""}, {""token"": ""ZDHHC18"", ""start_span"": 252, ""end_span"": 259, ""type"": ""Gene/Protein""}, {""token"": ""NUP214"", ""start_span"": 261, ""end_span"": 267, ""type"": ""Gene/Protein""}]"	train
The following pro - inflammatory cytokines were elevated early in D3 – 5 mouse retina compared to controls: VEGF ( F3, 39 = 3. 098, p = 0. 039 ), IL - 12 ( F3, 39 = 3. 982, p = 0. 015 ), IL - 17 ( F3, 39 = 3. 693, p = 0. 020 ), IL - 1α ( F3, 36 = 2. 924, p = 0. 048 ), TNF - α ( F3, 38 = 3. 051, p = 0. 041 ), IFN - γ ( F3, 37 = 3. 904, p = 0. 017 ), MIG ( F3, 39 = 3. 453, p = 0. 030 ), MIP - 1α ( F3, 30 = 3. 255, p = 0. 032 ), and KC ( F3, 39 = 6. 311, p = 0. 009 ).	pro - inflammatory cytokines,14,42,Gene/Protein	mouse,73,78,Organism/Species	VEGF,108,112,Gene/Protein	IL - 12,146,153,Gene/Protein	IL - 17,187,194,Gene/Protein	IL - 1α,228,235,Gene/Protein	TNF - α,269,276,Gene/Protein	IFN - γ,310,317,Gene/Protein	MIG,351,354,Gene/Protein	MIP - 1α,388,396,Gene/Protein	KC,434,436,Gene/Protein	"[{""token"": ""pro - inflammatory cytokines"", ""start_span"": 14, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 73, ""end_span"": 78, ""type"": ""Organism/Species""}, {""token"": ""VEGF"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 146, ""end_span"": 153, ""type"": ""Gene/Protein""}, {""token"": ""IL - 17"", ""start_span"": 187, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1\u03b1"", ""start_span"": 228, ""end_span"": 235, ""type"": ""Gene/Protein""}, {""token"": ""TNF - \u03b1"", ""start_span"": 269, ""end_span"": 276, ""type"": ""Gene/Protein""}, {""token"": ""IFN - \u03b3"", ""start_span"": 310, ""end_span"": 317, ""type"": ""Gene/Protein""}, {""token"": ""MIG"", ""start_span"": 351, ""end_span"": 354, ""type"": ""Gene/Protein""}, {""token"": ""MIP - 1\u03b1"", ""start_span"": 388, ""end_span"": 396, ""type"": ""Gene/Protein""}, {""token"": ""KC"", ""start_span"": 434, ""end_span"": 436, ""type"": ""Gene/Protein""}]"	train
Cells were treated with 200 nM AngII for 24 hrs in the presence or absence of 2 mM metformin ( AMPK activator ), 10 μM losartan ( AngII type 1 receptor antagonist ), 5 μM compound C ( AMPK inhibitor ), 300 μM Nω - nitro - L - arginine methyl ester ( L - NAME, pan - NOS inhibitor ), 10 μM splitomicin ( SIRT1 inhibitor) or 10 μM pifithrin - α ( p53 inhibitor ).	AngII,31,36,Gene/Protein	metformin,83,92,Chemical/Drug	AMPK,95,99,Gene/Protein	losartan,119,127,Chemical/Drug	AngII type 1 receptor,130,151,Gene/Protein	AMPK,184,188,Gene/Protein	NOS,266,269,Gene/Protein	splitomicin,289,300,Chemical/Drug	SIRT1,303,308,Gene/Protein	pifithrin - α,329,342,Chemical/Drug	p53,345,348,Gene/Protein	"[{""token"": ""AngII"", ""start_span"": 31, ""end_span"": 36, ""type"": ""Gene/Protein""}, {""token"": ""metformin"", ""start_span"": 83, ""end_span"": 92, ""type"": ""Chemical/Drug""}, {""token"": ""AMPK"", ""start_span"": 95, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""losartan"", ""start_span"": 119, ""end_span"": 127, ""type"": ""Chemical/Drug""}, {""token"": ""AngII type 1 receptor"", ""start_span"": 130, ""end_span"": 151, ""type"": ""Gene/Protein""}, {""token"": ""AMPK"", ""start_span"": 184, ""end_span"": 188, ""type"": ""Gene/Protein""}, {""token"": ""NOS"", ""start_span"": 266, ""end_span"": 269, ""type"": ""Gene/Protein""}, {""token"": ""splitomicin"", ""start_span"": 289, ""end_span"": 300, ""type"": ""Chemical/Drug""}, {""token"": ""SIRT1"", ""start_span"": 303, ""end_span"": 308, ""type"": ""Gene/Protein""}, {""token"": ""pifithrin - \u03b1"", ""start_span"": 329, ""end_span"": 342, ""type"": ""Chemical/Drug""}, {""token"": ""p53"", ""start_span"": 345, ""end_span"": 348, ""type"": ""Gene/Protein""}]"	train
Group II consisted of non - communicable diseases ( NCD ): malignant neoplasms, respiratory disorders, mental and behavioral disorders, epilepsy, diseases of the circulatory system, diseases of the digestive system, diseases of the genitourinary system, skin disorders and congenital abnormalities.	non - communicable diseases,22,49,Disease/Disorder	NCD,52,55,Disease/Disorder	malignant neoplasms,59,78,Disease/Disorder	respiratory disorders,80,101,Disease/Disorder	mental and behavioral disorders,103,134,Disease/Disorder	epilepsy,136,144,Disease/Disorder	diseases of the circulatory system,146,180,Disease/Disorder	diseases of the digestive system,182,214,Disease/Disorder	diseases of the genitourinary system,216,252,Disease/Disorder	skin disorders,254,268,Disease/Disorder	congenital abnormalities,273,297,Disease/Disorder	"[{""token"": ""non - communicable diseases"", ""start_span"": 22, ""end_span"": 49, ""type"": ""Disease/Disorder""}, {""token"": ""NCD"", ""start_span"": 52, ""end_span"": 55, ""type"": ""Disease/Disorder""}, {""token"": ""malignant neoplasms"", ""start_span"": 59, ""end_span"": 78, ""type"": ""Disease/Disorder""}, {""token"": ""respiratory disorders"", ""start_span"": 80, ""end_span"": 101, ""type"": ""Disease/Disorder""}, {""token"": ""mental and behavioral disorders"", ""start_span"": 103, ""end_span"": 134, ""type"": ""Disease/Disorder""}, {""token"": ""epilepsy"", ""start_span"": 136, ""end_span"": 144, ""type"": ""Disease/Disorder""}, {""token"": ""diseases of the circulatory system"", ""start_span"": 146, ""end_span"": 180, ""type"": ""Disease/Disorder""}, {""token"": ""diseases of the digestive system"", ""start_span"": 182, ""end_span"": 214, ""type"": ""Disease/Disorder""}, {""token"": ""diseases of the genitourinary system"", ""start_span"": 216, ""end_span"": 252, ""type"": ""Disease/Disorder""}, {""token"": ""skin disorders"", ""start_span"": 254, ""end_span"": 268, ""type"": ""Disease/Disorder""}, {""token"": ""congenital abnormalities"", ""start_span"": 273, ""end_span"": 297, ""type"": ""Disease/Disorder""}]"	train
Assessed comorbidities were hypertension, heart disease, macroangiopathy ( coronary, cerebrovascular, or peripheral artery disease ), microangiopathy ( renal, retinopathy, or neuropathy ), depression, asthma, chronic obstructive pulmonary disease, and cancer.	hypertension,28,40,Disease/Disorder	heart disease,42,55,Disease/Disorder	macroangiopathy,57,72,Disease/Disorder	peripheral artery disease,105,130,Disease/Disorder	microangiopathy,134,149,Disease/Disorder	retinopathy,159,170,Disease/Disorder	neuropathy,175,185,Disease/Disorder	depression,189,199,Disease/Disorder	asthma,201,207,Disease/Disorder	chronic obstructive pulmonary disease,209,246,Disease/Disorder	cancer,252,258,Disease/Disorder	"[{""token"": ""hypertension"", ""start_span"": 28, ""end_span"": 40, ""type"": ""Disease/Disorder""}, {""token"": ""heart disease"", ""start_span"": 42, ""end_span"": 55, ""type"": ""Disease/Disorder""}, {""token"": ""macroangiopathy"", ""start_span"": 57, ""end_span"": 72, ""type"": ""Disease/Disorder""}, {""token"": ""peripheral artery disease"", ""start_span"": 105, ""end_span"": 130, ""type"": ""Disease/Disorder""}, {""token"": ""microangiopathy"", ""start_span"": 134, ""end_span"": 149, ""type"": ""Disease/Disorder""}, {""token"": ""retinopathy"", ""start_span"": 159, ""end_span"": 170, ""type"": ""Disease/Disorder""}, {""token"": ""neuropathy"", ""start_span"": 175, ""end_span"": 185, ""type"": ""Disease/Disorder""}, {""token"": ""depression"", ""start_span"": 189, ""end_span"": 199, ""type"": ""Disease/Disorder""}, {""token"": ""asthma"", ""start_span"": 201, ""end_span"": 207, ""type"": ""Disease/Disorder""}, {""token"": ""chronic obstructive pulmonary disease"", ""start_span"": 209, ""end_span"": 246, ""type"": ""Disease/Disorder""}, {""token"": ""cancer"", ""start_span"": 252, ""end_span"": 258, ""type"": ""Disease/Disorder""}]"	train
Six species of the catfish family Doradidae were used for this study: Acanthodoras spinosissimus ( talking catfish) ( standard length 55. 1 – 113. 2 mm, N = 3 ), Agamyxis pectinifrons ( whitebarred catfish) ( 54. 8 – 59. 4 mm, N = 7 ), Amblydoras affinis ( 53 – 71. 2 mm, N = 7 ), Hemidoras morrisi ( 71 – 87. 3 mm, n = 9 ), Megalodoras uranoscopus ( 69. 6 – 122. 7 mm, N = 9) and Oxydoras niger ( ripsaw catfish) ( 105 – 168 mm, N = 3 ).	catfish,19,26,Organism/Species	Doradidae,34,43,Organism/Species	Acanthodoras spinosissimus,70,96,Organism/Species	talking catfish,99,114,Organism/Species	Agamyxis pectinifrons,162,183,Organism/Species	whitebarred catfish,186,205,Organism/Species	Amblydoras affinis,236,254,Organism/Species	Hemidoras morrisi,281,298,Organism/Species	Megalodoras uranoscopus,325,348,Organism/Species	Oxydoras niger,381,395,Organism/Species	ripsaw catfish,398,412,Organism/Species	"[{""token"": ""catfish"", ""start_span"": 19, ""end_span"": 26, ""type"": ""Organism/Species""}, {""token"": ""Doradidae"", ""start_span"": 34, ""end_span"": 43, ""type"": ""Organism/Species""}, {""token"": ""Acanthodoras spinosissimus"", ""start_span"": 70, ""end_span"": 96, ""type"": ""Organism/Species""}, {""token"": ""talking catfish"", ""start_span"": 99, ""end_span"": 114, ""type"": ""Organism/Species""}, {""token"": ""Agamyxis pectinifrons"", ""start_span"": 162, ""end_span"": 183, ""type"": ""Organism/Species""}, {""token"": ""whitebarred catfish"", ""start_span"": 186, ""end_span"": 205, ""type"": ""Organism/Species""}, {""token"": ""Amblydoras affinis"", ""start_span"": 236, ""end_span"": 254, ""type"": ""Organism/Species""}, {""token"": ""Hemidoras morrisi"", ""start_span"": 281, ""end_span"": 298, ""type"": ""Organism/Species""}, {""token"": ""Megalodoras uranoscopus"", ""start_span"": 325, ""end_span"": 348, ""type"": ""Organism/Species""}, {""token"": ""Oxydoras niger"", ""start_span"": 381, ""end_span"": 395, ""type"": ""Organism/Species""}, {""token"": ""ripsaw catfish"", ""start_span"": 398, ""end_span"": 412, ""type"": ""Organism/Species""}]"	train
We compared gene expression changes in DNA repair - related genes in Rad54 and Parp - 1 single ( Rad54 -/-/ Ptc1 +/-; Parp - 1 -/-/ Ptc1 +/-) and combined mutants ( Rad54 -/-/ Parp - 1 -/-/ Ptc1 +/-) versus Ptc1 +/- mice.	Rad54,69,74,Gene/Protein	Parp - 1,79,87,Gene/Protein	Rad54,97,102,Gene/Protein	Ptc1,108,112,Gene/Protein	Parp - 1,118,126,Gene/Protein	Ptc1,132,136,Gene/Protein	Rad54,165,170,Gene/Protein	Parp - 1,176,184,Gene/Protein	Ptc1,190,194,Gene/Protein	Ptc1,207,211,Gene/Protein	mice,216,220,Organism/Species	"[{""token"": ""Rad54"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 79, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""Rad54"", ""start_span"": 97, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 108, ""end_span"": 112, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 118, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 132, ""end_span"": 136, ""type"": ""Gene/Protein""}, {""token"": ""Rad54"", ""start_span"": 165, ""end_span"": 170, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 176, ""end_span"": 184, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 190, ""end_span"": 194, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 207, ""end_span"": 211, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 216, ""end_span"": 220, ""type"": ""Organism/Species""}]"	train
We detected strong downregulation of Prkdc ( DNA - PKcs ), which was unexpected as DNA - PKcs activation has been invoked to explain the synthetic lethal effects of Parp - 1 inhibitors in HR - defective cells [ 32 ]. DNA - PKcs downregulation was paralleled by marked downregulation of Atm. DNA - PKcs and Atm are both members of the phosphatidylinositol 3 - kinase ( PI3K )- related protein kinase superfamily and act in tandem by important cross - talk [ 33, 34 ].	Prkdc,37,42,Gene/Protein	DNA - PKcs,45,55,Gene/Protein	DNA - PKcs,83,93,Gene/Protein	Parp - 1,165,173,Gene/Protein	DNA - PKcs,217,227,Gene/Protein	Atm,286,289,Gene/Protein	DNA - PKcs,291,301,Gene/Protein	Atm,306,309,Gene/Protein	phosphatidylinositol 3 - kinase,334,365,Gene/Protein	PI3K,368,372,Gene/Protein	protein kinase,384,398,Gene/Protein	"[{""token"": ""Prkdc"", ""start_span"": 37, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""DNA - PKcs"", ""start_span"": 45, ""end_span"": 55, ""type"": ""Gene/Protein""}, {""token"": ""DNA - PKcs"", ""start_span"": 83, ""end_span"": 93, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 165, ""end_span"": 173, ""type"": ""Gene/Protein""}, {""token"": ""DNA - PKcs"", ""start_span"": 217, ""end_span"": 227, ""type"": ""Gene/Protein""}, {""token"": ""Atm"", ""start_span"": 286, ""end_span"": 289, ""type"": ""Gene/Protein""}, {""token"": ""DNA - PKcs"", ""start_span"": 291, ""end_span"": 301, ""type"": ""Gene/Protein""}, {""token"": ""Atm"", ""start_span"": 306, ""end_span"": 309, ""type"": ""Gene/Protein""}, {""token"": ""phosphatidylinositol 3 - kinase"", ""start_span"": 334, ""end_span"": 365, ""type"": ""Gene/Protein""}, {""token"": ""PI3K"", ""start_span"": 368, ""end_span"": 372, ""type"": ""Gene/Protein""}, {""token"": ""protein kinase"", ""start_span"": 384, ""end_span"": 398, ""type"": ""Gene/Protein""}]"	train
Ki - 67 quantification: Three to 7 sections from EGL of Ptc1 +/-, Rad54 -/-/ Ptc1 +/-, Parp - 1 -/-/ Ptc1 +/- and Rad54 -/-/ Parp - 1 -/-/ Ptc1 +/- mice were immunostained for Ki67.	Ki - 67,0,7,Gene/Protein	Ptc1,56,60,Gene/Protein	Rad54,66,71,Gene/Protein	Ptc1,77,81,Gene/Protein	Parp - 1,87,95,Gene/Protein	Ptc1,101,105,Gene/Protein	Rad54,114,119,Gene/Protein	Parp - 1,125,133,Gene/Protein	Ptc1,139,143,Gene/Protein	mice,148,152,Organism/Species	Ki67,176,180,Gene/Protein	"[{""token"": ""Ki - 67"", ""start_span"": 0, ""end_span"": 7, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 56, ""end_span"": 60, ""type"": ""Gene/Protein""}, {""token"": ""Rad54"", ""start_span"": 66, ""end_span"": 71, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 77, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 87, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 101, ""end_span"": 105, ""type"": ""Gene/Protein""}, {""token"": ""Rad54"", ""start_span"": 114, ""end_span"": 119, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 125, ""end_span"": 133, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 139, ""end_span"": 143, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 148, ""end_span"": 152, ""type"": ""Organism/Species""}, {""token"": ""Ki67"", ""start_span"": 176, ""end_span"": 180, ""type"": ""Gene/Protein""}]"	train
NeuN quantification: Three to 5 cerebellum sections of Ptc1 +/-, Parp - 1 -/-/ Ptc1 +/-, Rad54 -/-/ Ptc1 +/- and Rad54 -/-/ Parp - 1 -/-/ Ptc1 +/- mice were immunostained for NeuN.	NeuN,0,4,Gene/Protein	Ptc1,55,59,Gene/Protein	Parp - 1,65,73,Gene/Protein	Ptc1,79,83,Gene/Protein	Rad54,89,94,Gene/Protein	Ptc1,100,104,Gene/Protein	Rad54,113,118,Gene/Protein	Parp - 1,124,132,Gene/Protein	Ptc1,138,142,Gene/Protein	mice,147,151,Organism/Species	NeuN,175,179,Gene/Protein	"[{""token"": ""NeuN"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 55, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 65, ""end_span"": 73, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 79, ""end_span"": 83, ""type"": ""Gene/Protein""}, {""token"": ""Rad54"", ""start_span"": 89, ""end_span"": 94, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 100, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""Rad54"", ""start_span"": 113, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""Parp - 1"", ""start_span"": 124, ""end_span"": 132, ""type"": ""Gene/Protein""}, {""token"": ""Ptc1"", ""start_span"": 138, ""end_span"": 142, ""type"": ""Gene/Protein""}, {""token"": ""mice"", ""start_span"": 147, ""end_span"": 151, ""type"": ""Organism/Species""}, {""token"": ""NeuN"", ""start_span"": 175, ""end_span"": 179, ""type"": ""Gene/Protein""}]"	train
The degree of blood parasite infection reported varies greatly among birds, including taxa with high prevalence ( e. g. songbirds ), but also taxa with low prevalence ( e. g. some seabirds) or even an absence of parasites ( e. g. storks, waders, nightjars, some seabirds, sandgrouse, parrots, swifts) [ 24, 30 – 44 ].	infection,29,38,Disease/Disorder	birds,69,74,Organism/Species	songbirds,120,129,Organism/Species	seabirds,180,188,Organism/Species	storks,230,236,Organism/Species	waders,238,244,Organism/Species	nightjars,246,255,Organism/Species	seabirds,262,270,Organism/Species	sandgrouse,272,282,Organism/Species	parrots,284,291,Organism/Species	swifts,293,299,Organism/Species	"[{""token"": ""infection"", ""start_span"": 29, ""end_span"": 38, ""type"": ""Disease/Disorder""}, {""token"": ""birds"", ""start_span"": 69, ""end_span"": 74, ""type"": ""Organism/Species""}, {""token"": ""songbirds"", ""start_span"": 120, ""end_span"": 129, ""type"": ""Organism/Species""}, {""token"": ""seabirds"", ""start_span"": 180, ""end_span"": 188, ""type"": ""Organism/Species""}, {""token"": ""storks"", ""start_span"": 230, ""end_span"": 236, ""type"": ""Organism/Species""}, {""token"": ""waders"", ""start_span"": 238, ""end_span"": 244, ""type"": ""Organism/Species""}, {""token"": ""nightjars"", ""start_span"": 246, ""end_span"": 255, ""type"": ""Organism/Species""}, {""token"": ""seabirds"", ""start_span"": 262, ""end_span"": 270, ""type"": ""Organism/Species""}, {""token"": ""sandgrouse"", ""start_span"": 272, ""end_span"": 282, ""type"": ""Organism/Species""}, {""token"": ""parrots"", ""start_span"": 284, ""end_span"": 291, ""type"": ""Organism/Species""}, {""token"": ""swifts"", ""start_span"": 293, ""end_span"": 299, ""type"": ""Organism/Species""}]"	train
The HBV - HCV co - infection group had higher ALT, AST, ALP, GGT, APRI and FIB - 4 levels, but lower ALB and total platelet compared to the HBV mono - infection group, and similar to that of the HCV mono - infected group.	HBV,4,7,Organism/Species	HCV,10,13,Organism/Species	co - infection,14,28,Disease/Disorder	ALT,46,49,Gene/Protein	AST,51,54,Gene/Protein	ALP,56,59,Gene/Protein	GGT,61,64,Gene/Protein	ALB,101,104,Gene/Protein	HBV,140,143,Organism/Species	infection,151,160,Disease/Disorder	HCV,195,198,Organism/Species	"[{""token"": ""HBV"", ""start_span"": 4, ""end_span"": 7, ""type"": ""Organism/Species""}, {""token"": ""HCV"", ""start_span"": 10, ""end_span"": 13, ""type"": ""Organism/Species""}, {""token"": ""co - infection"", ""start_span"": 14, ""end_span"": 28, ""type"": ""Disease/Disorder""}, {""token"": ""ALT"", ""start_span"": 46, ""end_span"": 49, ""type"": ""Gene/Protein""}, {""token"": ""AST"", ""start_span"": 51, ""end_span"": 54, ""type"": ""Gene/Protein""}, {""token"": ""ALP"", ""start_span"": 56, ""end_span"": 59, ""type"": ""Gene/Protein""}, {""token"": ""GGT"", ""start_span"": 61, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""ALB"", ""start_span"": 101, ""end_span"": 104, ""type"": ""Gene/Protein""}, {""token"": ""HBV"", ""start_span"": 140, ""end_span"": 143, ""type"": ""Organism/Species""}, {""token"": ""infection"", ""start_span"": 151, ""end_span"": 160, ""type"": ""Disease/Disorder""}, {""token"": ""HCV"", ""start_span"": 195, ""end_span"": 198, ""type"": ""Organism/Species""}]"	train
To characterize cells undergoing an active transcriptional response to expression of these transgenes, we crossed MMTV - Wnt1 and MMTV - ΔN89β - catenin lines to the Axin2 - d2EGFP reporter mouse, isolated tumor MECs from the bitransgenic progeny and analyzed them for enhanced green fluorescent protein ( EGFP) and CD24 / CD49f expression by flow cytometry.	MMTV,114,118,Organism/Species	Wnt1,121,125,Gene/Protein	MMTV,130,134,Organism/Species	Axin2,166,171,Gene/Protein	reporter,181,189,Gene/Protein	mouse,190,195,Organism/Species	tumor,206,211,Disease/Disorder	enhanced green fluorescent protein,269,303,Gene/Protein	EGFP,306,310,Gene/Protein	CD24,316,320,Gene/Protein	CD49f,323,328,Gene/Protein	"[{""token"": ""MMTV"", ""start_span"": 114, ""end_span"": 118, ""type"": ""Organism/Species""}, {""token"": ""Wnt1"", ""start_span"": 121, ""end_span"": 125, ""type"": ""Gene/Protein""}, {""token"": ""MMTV"", ""start_span"": 130, ""end_span"": 134, ""type"": ""Organism/Species""}, {""token"": ""Axin2"", ""start_span"": 166, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""reporter"", ""start_span"": 181, ""end_span"": 189, ""type"": ""Gene/Protein""}, {""token"": ""mouse"", ""start_span"": 190, ""end_span"": 195, ""type"": ""Organism/Species""}, {""token"": ""tumor"", ""start_span"": 206, ""end_span"": 211, ""type"": ""Disease/Disorder""}, {""token"": ""enhanced green fluorescent protein"", ""start_span"": 269, ""end_span"": 303, ""type"": ""Gene/Protein""}, {""token"": ""EGFP"", ""start_span"": 306, ""end_span"": 310, ""type"": ""Gene/Protein""}, {""token"": ""CD24"", ""start_span"": 316, ""end_span"": 320, ""type"": ""Gene/Protein""}, {""token"": ""CD49f"", ""start_span"": 323, ""end_span"": 328, ""type"": ""Gene/Protein""}]"	train
The concentrations of cytokines ( interleukin ( IL )- 1β, IL - 4, IL - 6, IL - 10, IL - 12, IL - 13, interferon ( IFN )- γ, tumor necrosis factor ( TNF )- α, and IL - 17) and the chemokine ( CC - motif) ligand 5 ( CCL5) were measured using a Bio - Plex Luminex 100 ( Biorad ).	cytokines,22,31,Gene/Protein	interleukin,34,45,Gene/Protein	IL - 4,58,64,Gene/Protein	IL - 6,66,72,Gene/Protein	IL - 10,74,81,Gene/Protein	IL - 12,83,90,Gene/Protein	IL - 13,92,99,Gene/Protein	interferon,101,111,Gene/Protein	tumor necrosis factor,124,145,Gene/Protein	IL - 17,162,169,Gene/Protein	CCL5,214,218,Gene/Protein	"[{""token"": ""cytokines"", ""start_span"": 22, ""end_span"": 31, ""type"": ""Gene/Protein""}, {""token"": ""interleukin"", ""start_span"": 34, ""end_span"": 45, ""type"": ""Gene/Protein""}, {""token"": ""IL - 4"", ""start_span"": 58, ""end_span"": 64, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 66, ""end_span"": 72, ""type"": ""Gene/Protein""}, {""token"": ""IL - 10"", ""start_span"": 74, ""end_span"": 81, ""type"": ""Gene/Protein""}, {""token"": ""IL - 12"", ""start_span"": 83, ""end_span"": 90, ""type"": ""Gene/Protein""}, {""token"": ""IL - 13"", ""start_span"": 92, ""end_span"": 99, ""type"": ""Gene/Protein""}, {""token"": ""interferon"", ""start_span"": 101, ""end_span"": 111, ""type"": ""Gene/Protein""}, {""token"": ""tumor necrosis factor"", ""start_span"": 124, ""end_span"": 145, ""type"": ""Gene/Protein""}, {""token"": ""IL - 17"", ""start_span"": 162, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""CCL5"", ""start_span"": 214, ""end_span"": 218, ""type"": ""Gene/Protein""}]"	train
The transcripts of cytokine interleukin 1β ( IL - 1β ), IL - 6, CXCLi1, CXCLi2, tumor growth factor β4 ( TGF - β4) and the inducible nitric oxide synthese ( iNOS) were measured in inoculated and mock - inoculated cells using qPCR relative to β - actin.	cytokine,19,27,Gene/Protein	interleukin 1β,28,42,Gene/Protein	IL - 1β,45,52,Gene/Protein	IL - 6,56,62,Gene/Protein	CXCLi1,64,70,Gene/Protein	CXCLi2,72,78,Gene/Protein	tumor growth factor β4,80,102,Gene/Protein	TGF - β4,105,113,Gene/Protein	inducible nitric oxide synthese,123,154,Gene/Protein	iNOS,157,161,Gene/Protein	β - actin,242,251,Gene/Protein	"[{""token"": ""cytokine"", ""start_span"": 19, ""end_span"": 27, ""type"": ""Gene/Protein""}, {""token"": ""interleukin 1\u03b2"", ""start_span"": 28, ""end_span"": 42, ""type"": ""Gene/Protein""}, {""token"": ""IL - 1\u03b2"", ""start_span"": 45, ""end_span"": 52, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 56, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""CXCLi1"", ""start_span"": 64, ""end_span"": 70, ""type"": ""Gene/Protein""}, {""token"": ""CXCLi2"", ""start_span"": 72, ""end_span"": 78, ""type"": ""Gene/Protein""}, {""token"": ""tumor growth factor \u03b24"", ""start_span"": 80, ""end_span"": 102, ""type"": ""Gene/Protein""}, {""token"": ""TGF - \u03b24"", ""start_span"": 105, ""end_span"": 113, ""type"": ""Gene/Protein""}, {""token"": ""inducible nitric oxide synthese"", ""start_span"": 123, ""end_span"": 154, ""type"": ""Gene/Protein""}, {""token"": ""iNOS"", ""start_span"": 157, ""end_span"": 161, ""type"": ""Gene/Protein""}, {""token"": ""\u03b2 - actin"", ""start_span"": 242, ""end_span"": 251, ""type"": ""Gene/Protein""}]"	train
Since metalloproteases can cleave proBDNF or p75NTR, in parallel we tested whether adding GM6001, an inhibitor of metalloproteases increased the yield of endogenous p75NTR or SorCS2 pulled out using this procedure. Fig 7 shows that p75NTR and SorCS2 were readily co - purified in a complex with HBpF - proBDNF but only in cells incubated with GM6001 ( 9μM ).	metalloproteases,6,22,Gene/Protein	proBDNF,34,41,Gene/Protein	p75NTR,45,51,Gene/Protein	GM6001,90,96,Chemical/Drug	metalloproteases,114,130,Gene/Protein	p75NTR,165,171,Gene/Protein	SorCS2,175,181,Gene/Protein	p75NTR,232,238,Gene/Protein	SorCS2,243,249,Gene/Protein	proBDNF,302,309,Gene/Protein	GM6001,343,349,Chemical/Drug	"[{""token"": ""metalloproteases"", ""start_span"": 6, ""end_span"": 22, ""type"": ""Gene/Protein""}, {""token"": ""proBDNF"", ""start_span"": 34, ""end_span"": 41, ""type"": ""Gene/Protein""}, {""token"": ""p75NTR"", ""start_span"": 45, ""end_span"": 51, ""type"": ""Gene/Protein""}, {""token"": ""GM6001"", ""start_span"": 90, ""end_span"": 96, ""type"": ""Chemical/Drug""}, {""token"": ""metalloproteases"", ""start_span"": 114, ""end_span"": 130, ""type"": ""Gene/Protein""}, {""token"": ""p75NTR"", ""start_span"": 165, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""SorCS2"", ""start_span"": 175, ""end_span"": 181, ""type"": ""Gene/Protein""}, {""token"": ""p75NTR"", ""start_span"": 232, ""end_span"": 238, ""type"": ""Gene/Protein""}, {""token"": ""SorCS2"", ""start_span"": 243, ""end_span"": 249, ""type"": ""Gene/Protein""}, {""token"": ""proBDNF"", ""start_span"": 302, ""end_span"": 309, ""type"": ""Gene/Protein""}, {""token"": ""GM6001"", ""start_span"": 343, ""end_span"": 349, ""type"": ""Chemical/Drug""}]"	train
In this respect it has been reported that ( a) Salmonella actively invades plant cells, proliferates there and can cause disease symptoms ( Schikora et al ., 2008; Berger et al ., 2011) ( b) the plant recognizes Salmonella and plant defense responses are activated ( Iniguez et al ., 2005; Schikora et al ., 2008) and ( c) that functional Type Three Secretion Systems ( TTSS) 1 and 2 are important for Salmonella pathogenicity in plants with respect to bacterial proliferation and suppression of plant defense responses ( Iniguez et al ., 2005; Schikora et al ., 2011; Shirron and Yaron, 2011 ). Salmonella TTSS - 1 and 2 encode proteins, so called effectors, which are known to be translocated into the animal host cell in order to manipulate host cell mechanisms mainly via PPIs ( Schleker et al ., 2012 ).	Salmonella,47,57,Organism/Species	plant,75,80,Organism/Species	plant,195,200,Organism/Species	Salmonella,212,222,Organism/Species	plant,227,232,Organism/Species	Type Three Secretion Systems,339,367,Gene/Protein	Salmonella,402,412,Organism/Species	plants,430,436,Organism/Species	plant,496,501,Organism/Species	Salmonella,596,606,Organism/Species	TTSS - 1,607,615,Gene/Protein	"[{""token"": ""Salmonella"", ""start_span"": 47, ""end_span"": 57, ""type"": ""Organism/Species""}, {""token"": ""plant"", ""start_span"": 75, ""end_span"": 80, ""type"": ""Organism/Species""}, {""token"": ""plant"", ""start_span"": 195, ""end_span"": 200, ""type"": ""Organism/Species""}, {""token"": ""Salmonella"", ""start_span"": 212, ""end_span"": 222, ""type"": ""Organism/Species""}, {""token"": ""plant"", ""start_span"": 227, ""end_span"": 232, ""type"": ""Organism/Species""}, {""token"": ""Type Three Secretion Systems"", ""start_span"": 339, ""end_span"": 367, ""type"": ""Gene/Protein""}, {""token"": ""Salmonella"", ""start_span"": 402, ""end_span"": 412, ""type"": ""Organism/Species""}, {""token"": ""plants"", ""start_span"": 430, ""end_span"": 436, ""type"": ""Organism/Species""}, {""token"": ""plant"", ""start_span"": 496, ""end_span"": 501, ""type"": ""Organism/Species""}, {""token"": ""Salmonella"", ""start_span"": 596, ""end_span"": 606, ""type"": ""Organism/Species""}, {""token"": ""TTSS - 1"", ""start_span"": 607, ""end_span"": 615, ""type"": ""Gene/Protein""}]"	train
Other examples that highlight the role of transcription factors in plant - pathogen interaction are e. g ., that a Xanthomonas effector protein targets an ethylene responsive transcription factor ( ERF) in tomato to inhibit ethylene induced transcription ( Kim et al ., 2013) and systemic immunity in barley induced by Xanthomonas and Pseudomonas bacteria may involve WRKY and ERF - like transcription factors ( Dey et al ., 2014 ).	plant,67,72,Organism/Species	Xanthomonas,115,126,Organism/Species	ethylene responsive transcription factor,155,195,Gene/Protein	ERF,198,201,Gene/Protein	tomato,206,212,Organism/Species	barley,301,307,Organism/Species	Xanthomonas,319,330,Organism/Species	Pseudomonas,335,346,Organism/Species	bacteria,347,355,Organism/Species	WRKY,368,372,Gene/Protein	ERF,377,380,Gene/Protein	"[{""token"": ""plant"", ""start_span"": 67, ""end_span"": 72, ""type"": ""Organism/Species""}, {""token"": ""Xanthomonas"", ""start_span"": 115, ""end_span"": 126, ""type"": ""Organism/Species""}, {""token"": ""ethylene responsive transcription factor"", ""start_span"": 155, ""end_span"": 195, ""type"": ""Gene/Protein""}, {""token"": ""ERF"", ""start_span"": 198, ""end_span"": 201, ""type"": ""Gene/Protein""}, {""token"": ""tomato"", ""start_span"": 206, ""end_span"": 212, ""type"": ""Organism/Species""}, {""token"": ""barley"", ""start_span"": 301, ""end_span"": 307, ""type"": ""Organism/Species""}, {""token"": ""Xanthomonas"", ""start_span"": 319, ""end_span"": 330, ""type"": ""Organism/Species""}, {""token"": ""Pseudomonas"", ""start_span"": 335, ""end_span"": 346, ""type"": ""Organism/Species""}, {""token"": ""bacteria"", ""start_span"": 347, ""end_span"": 355, ""type"": ""Organism/Species""}, {""token"": ""WRKY"", ""start_span"": 368, ""end_span"": 372, ""type"": ""Gene/Protein""}, {""token"": ""ERF"", ""start_span"": 377, ""end_span"": 380, ""type"": ""Gene/Protein""}]"	train
Neutral lipid droplets found in microalgae consist mostly of triacylglycerols ( TAGs ), formed by combining FAs and glycerol. Legend: ACCase, acetyl - CoA carboxylase; ACD, acyl - CoA dehydrogenase; ACL, ATP - citrate lyase; ACS, acyl - CoA synthetase; AGPP, ADP - glucose pyrophosphorylase; AMY, amylase; CA, carbonic anhydrase; DGAT, diacylglycerol acyltransferase; DHAP, dihydroxyacetone phosphate; F1, 6 P, fructose 1, 6 - bisphosphate; F6P, fructose 6 - phosphate; FAT, fatty acyl - acyl carrier protein ( ACP) thioesterase; G1P, glucose 1 - phosphate; G6P, glucose 6 - phosphate; G6PDH: G6P dehydrogenase, GAP, glyceraldehyde 3 - phosphate; GPAT, glycerol - 3 - phosphate acyltransferase; GPDH, glycerol - 3 - phosphate dehydrogenase; MAL, malate; MDH, malate dehydrogenase; MME: NADP - malic enzyme; OAA, oxaloacetate; PDC, pyruvate dehydrogenase complex; PEP, phosphoenolpyruvate; PEPC, PEP carboxylase; PK, pyruvate kinase; Ru5P, ribulose 5 - phosphate; Ru1, 5BP, ribulose 1, 5 - bisphosphate; RuBisCO, Ru1, 5BP carboxylase / oxygenase; TPT, triose phosphate translocator; 3 - PGA, 3 - phosphoglycerate; 6PGDH, 6 - phosphogluconate dehydrogenase.	triacylglycerols,61,77,Chemical/Drug	glycerol,116,124,Chemical/Drug	citrate,210,217,Chemical/Drug	glucose,265,272,Chemical/Drug	diacylglycerol,336,350,Chemical/Drug	fatty acyl,475,485,Chemical/Drug	glucose,535,542,Chemical/Drug	malate,746,752,Chemical/Drug	malate,759,765,Chemical/Drug	pyruvate,831,839,Chemical/Drug	pyruvate,879,887,Chemical/Drug	"[{""token"": ""triacylglycerols"", ""start_span"": 61, ""end_span"": 77, ""type"": ""Chemical/Drug""}, {""token"": ""glycerol"", ""start_span"": 116, ""end_span"": 124, ""type"": ""Chemical/Drug""}, {""token"": ""citrate"", ""start_span"": 210, ""end_span"": 217, ""type"": ""Chemical/Drug""}, {""token"": ""glucose"", ""start_span"": 265, ""end_span"": 272, ""type"": ""Chemical/Drug""}, {""token"": ""diacylglycerol"", ""start_span"": 336, ""end_span"": 350, ""type"": ""Chemical/Drug""}, {""token"": ""fatty acyl"", ""start_span"": 475, ""end_span"": 485, ""type"": ""Chemical/Drug""}, {""token"": ""glucose"", ""start_span"": 535, ""end_span"": 542, ""type"": ""Chemical/Drug""}, {""token"": ""malate"", ""start_span"": 746, ""end_span"": 752, ""type"": ""Chemical/Drug""}, {""token"": ""malate"", ""start_span"": 759, ""end_span"": 765, ""type"": ""Chemical/Drug""}, {""token"": ""pyruvate"", ""start_span"": 831, ""end_span"": 839, ""type"": ""Chemical/Drug""}, {""token"": ""pyruvate"", ""start_span"": 879, ""end_span"": 887, ""type"": ""Chemical/Drug""}]"	train
MSCs constitutively secrete a broad range of hematopoietic cytokines, such as IL - 6, IL - 7, IL - 8, IL - 11, IL - 14, IL - 15, macrophage colony - stimulating factor, Flt - 3 ligand, and stem - cell factor ( SFC ).	hematopoietic cytokines,45,68,Gene/Protein	IL - 6,78,84,Gene/Protein	IL - 7,86,92,Gene/Protein	IL - 8,94,100,Gene/Protein	IL - 11,102,109,Gene/Protein	IL - 14,111,118,Gene/Protein	IL - 15,120,127,Gene/Protein	macrophage colony - stimulating factor,129,167,Gene/Protein	Flt - 3 ligand,169,183,Gene/Protein	stem - cell factor,189,207,Gene/Protein	SFC,210,213,Gene/Protein	"[{""token"": ""hematopoietic cytokines"", ""start_span"": 45, ""end_span"": 68, ""type"": ""Gene/Protein""}, {""token"": ""IL - 6"", ""start_span"": 78, ""end_span"": 84, ""type"": ""Gene/Protein""}, {""token"": ""IL - 7"", ""start_span"": 86, ""end_span"": 92, ""type"": ""Gene/Protein""}, {""token"": ""IL - 8"", ""start_span"": 94, ""end_span"": 100, ""type"": ""Gene/Protein""}, {""token"": ""IL - 11"", ""start_span"": 102, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""IL - 14"", ""start_span"": 111, ""end_span"": 118, ""type"": ""Gene/Protein""}, {""token"": ""IL - 15"", ""start_span"": 120, ""end_span"": 127, ""type"": ""Gene/Protein""}, {""token"": ""macrophage colony - stimulating factor"", ""start_span"": 129, ""end_span"": 167, ""type"": ""Gene/Protein""}, {""token"": ""Flt - 3 ligand"", ""start_span"": 169, ""end_span"": 183, ""type"": ""Gene/Protein""}, {""token"": ""stem - cell factor"", ""start_span"": 189, ""end_span"": 207, ""type"": ""Gene/Protein""}, {""token"": ""SFC"", ""start_span"": 210, ""end_span"": 213, ""type"": ""Gene/Protein""}]"	train
AIDS, Acquired Immunodeficiency Syndrome; CSO, Civil Society Organization; CSPro, Census and Survey Processing System; DFID, Department for International Development; HAF, HIV / AIDS Fund; HERFON, Health Reform Foundation of Nigeria; HIV, Human Immunodeficiency Virus; NACA, National Agency for the Control of AIDS; PCA, Principal Components Analysis; PEPFAR, Presidents Emergency Plan for AIDS Relief; PPFN, Planned Parenthood Foundation of Nigeria; SACA, State AIDS Control Agency; SPSS, Statistical Package for the Social Sciences; UNAIDS, Joint United Nations Programme on HIV / AIDS; USAID, United States Agency for International Development	AIDS,0,4,Disease/Disorder	Acquired Immunodeficiency Syndrome,6,40,Disease/Disorder	HIV,172,175,Organism/Species	AIDS,178,182,Disease/Disorder	HIV,234,237,Organism/Species	Human Immunodeficiency Virus,239,267,Organism/Species	AIDS,310,314,Disease/Disorder	AIDS,390,394,Disease/Disorder	AIDS,463,467,Disease/Disorder	HIV,577,580,Organism/Species	AIDS,583,587,Disease/Disorder	"[{""token"": ""AIDS"", ""start_span"": 0, ""end_span"": 4, ""type"": ""Disease/Disorder""}, {""token"": ""Acquired Immunodeficiency Syndrome"", ""start_span"": 6, ""end_span"": 40, ""type"": ""Disease/Disorder""}, {""token"": ""HIV"", ""start_span"": 172, ""end_span"": 175, ""type"": ""Organism/Species""}, {""token"": ""AIDS"", ""start_span"": 178, ""end_span"": 182, ""type"": ""Disease/Disorder""}, {""token"": ""HIV"", ""start_span"": 234, ""end_span"": 237, ""type"": ""Organism/Species""}, {""token"": ""Human Immunodeficiency Virus"", ""start_span"": 239, ""end_span"": 267, ""type"": ""Organism/Species""}, {""token"": ""AIDS"", ""start_span"": 310, ""end_span"": 314, ""type"": ""Disease/Disorder""}, {""token"": ""AIDS"", ""start_span"": 390, ""end_span"": 394, ""type"": ""Disease/Disorder""}, {""token"": ""AIDS"", ""start_span"": 463, ""end_span"": 467, ""type"": ""Disease/Disorder""}, {""token"": ""HIV"", ""start_span"": 577, ""end_span"": 580, ""type"": ""Organism/Species""}, {""token"": ""AIDS"", ""start_span"": 583, ""end_span"": 587, ""type"": ""Disease/Disorder""}]"	train
In an attempt to find mRNA markers that would help to identify a newly transformed oocyst and distinguish it from other parasite stages that may be present in the culture, we looked at the following well - characterised housekeeping or putative ookinete / early oocyst - specific molecules for signs of changes in transcription: CTRP, WARP, sporozoite microneme protein essential for cell traversal ( SPECT ), Myosin A, hypoxanthine – guanine phosphorybosyltransferase ( HGPRT ), scavenger receptor, P28, RNA S and circumsporozoite protein ( CSP ).	CTRP,329,333,Gene/Protein	WARP,335,339,Gene/Protein	sporozoite microneme protein essential for cell traversal,341,398,Gene/Protein	SPECT,401,406,Gene/Protein	Myosin A,410,418,Gene/Protein	hypoxanthine – guanine phosphorybosyltransferase,420,468,Gene/Protein	HGPRT,471,476,Gene/Protein	scavenger receptor,480,498,Gene/Protein	P28,500,503,Gene/Protein	circumsporozoite protein,515,539,Gene/Protein	CSP,542,545,Gene/Protein	"[{""token"": ""CTRP"", ""start_span"": 329, ""end_span"": 333, ""type"": ""Gene/Protein""}, {""token"": ""WARP"", ""start_span"": 335, ""end_span"": 339, ""type"": ""Gene/Protein""}, {""token"": ""sporozoite microneme protein essential for cell traversal"", ""start_span"": 341, ""end_span"": 398, ""type"": ""Gene/Protein""}, {""token"": ""SPECT"", ""start_span"": 401, ""end_span"": 406, ""type"": ""Gene/Protein""}, {""token"": ""Myosin A"", ""start_span"": 410, ""end_span"": 418, ""type"": ""Gene/Protein""}, {""token"": ""hypoxanthine \u2013 guanine phosphorybosyltransferase"", ""start_span"": 420, ""end_span"": 468, ""type"": ""Gene/Protein""}, {""token"": ""HGPRT"", ""start_span"": 471, ""end_span"": 476, ""type"": ""Gene/Protein""}, {""token"": ""scavenger receptor"", ""start_span"": 480, ""end_span"": 498, ""type"": ""Gene/Protein""}, {""token"": ""P28"", ""start_span"": 500, ""end_span"": 503, ""type"": ""Gene/Protein""}, {""token"": ""circumsporozoite protein"", ""start_span"": 515, ""end_span"": 539, ""type"": ""Gene/Protein""}, {""token"": ""CSP"", ""start_span"": 542, ""end_span"": 545, ""type"": ""Gene/Protein""}]"	train
DNA hypermethylation was observed in genes related to fatty acid transport and synthesis ( LDLR, FATP, Glyctk, DGAT1 and DGAT2) and fatty acid oxidation ( CPT - 2, MCAD, CYP4A, ACO ).	fatty acid,54,64,Chemical/Drug	LDLR,91,95,Gene/Protein	FATP,97,101,Gene/Protein	Glyctk,103,109,Gene/Protein	DGAT1,111,116,Gene/Protein	DGAT2,121,126,Gene/Protein	fatty acid,132,142,Chemical/Drug	CPT - 2,155,162,Gene/Protein	MCAD,164,168,Gene/Protein	CYP4A,170,175,Gene/Protein	ACO,177,180,Gene/Protein	"[{""token"": ""fatty acid"", ""start_span"": 54, ""end_span"": 64, ""type"": ""Chemical/Drug""}, {""token"": ""LDLR"", ""start_span"": 91, ""end_span"": 95, ""type"": ""Gene/Protein""}, {""token"": ""FATP"", ""start_span"": 97, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""Glyctk"", ""start_span"": 103, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""DGAT1"", ""start_span"": 111, ""end_span"": 116, ""type"": ""Gene/Protein""}, {""token"": ""DGAT2"", ""start_span"": 121, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""fatty acid"", ""start_span"": 132, ""end_span"": 142, ""type"": ""Chemical/Drug""}, {""token"": ""CPT - 2"", ""start_span"": 155, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""MCAD"", ""start_span"": 164, ""end_span"": 168, ""type"": ""Gene/Protein""}, {""token"": ""CYP4A"", ""start_span"": 170, ""end_span"": 175, ""type"": ""Gene/Protein""}, {""token"": ""ACO"", ""start_span"": 177, ""end_span"": 180, ""type"": ""Gene/Protein""}]"	train
The TNFRSF includes costimulatory molecules such as CD40, CD30, Herpes virus entry mediator ( HVEM ), 4 - 1BB, OX40, CD27, DR3, and glucocorticoid - induced TNFR - related protein ( GITR) 18.	TNFRSF,4,10,Gene/Protein	CD40,52,56,Gene/Protein	CD30,58,62,Gene/Protein	Herpes virus entry mediator,64,91,Gene/Protein	HVEM,94,98,Gene/Protein	4 - 1BB,102,109,Gene/Protein	OX40,111,115,Gene/Protein	CD27,117,121,Gene/Protein	DR3,123,126,Gene/Protein	glucocorticoid - induced TNFR - related protein,132,179,Gene/Protein	GITR,182,186,Gene/Protein	"[{""token"": ""TNFRSF"", ""start_span"": 4, ""end_span"": 10, ""type"": ""Gene/Protein""}, {""token"": ""CD40"", ""start_span"": 52, ""end_span"": 56, ""type"": ""Gene/Protein""}, {""token"": ""CD30"", ""start_span"": 58, ""end_span"": 62, ""type"": ""Gene/Protein""}, {""token"": ""Herpes virus entry mediator"", ""start_span"": 64, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""HVEM"", ""start_span"": 94, ""end_span"": 98, ""type"": ""Gene/Protein""}, {""token"": ""4 - 1BB"", ""start_span"": 102, ""end_span"": 109, ""type"": ""Gene/Protein""}, {""token"": ""OX40"", ""start_span"": 111, ""end_span"": 115, ""type"": ""Gene/Protein""}, {""token"": ""CD27"", ""start_span"": 117, ""end_span"": 121, ""type"": ""Gene/Protein""}, {""token"": ""DR3"", ""start_span"": 123, ""end_span"": 126, ""type"": ""Gene/Protein""}, {""token"": ""glucocorticoid - induced TNFR - related protein"", ""start_span"": 132, ""end_span"": 179, ""type"": ""Gene/Protein""}, {""token"": ""GITR"", ""start_span"": 182, ""end_span"": 186, ""type"": ""Gene/Protein""}]"	train
In a previous report, mice with a targeted deletion of the Tnfrsf21 gene ( encoding DR6) exhibited hyper production of immunoglobulins after antigen stimulation19, and DR6 deficiency in peripheral T cells enhances the production of cytokines for facilitating B cell activation and differentiation, as well as the antigen - dependent activation of transcriptional factors such as the nuclear factor of activated T cells ( NFAT) or nuclear factor - kappa B ( NFκB) 20.	mice,22,26,Organism/Species	Tnfrsf21,59,67,Gene/Protein	DR6,84,87,Gene/Protein	immunoglobulins,119,134,Gene/Protein	DR6,168,171,Gene/Protein	cytokines,232,241,Gene/Protein	transcriptional factors,347,370,Gene/Protein	nuclear factor of activated T cells,383,418,Gene/Protein	NFAT,421,425,Gene/Protein	nuclear factor - kappa B,430,454,Gene/Protein	NFκB,457,461,Gene/Protein	"[{""token"": ""mice"", ""start_span"": 22, ""end_span"": 26, ""type"": ""Organism/Species""}, {""token"": ""Tnfrsf21"", ""start_span"": 59, ""end_span"": 67, ""type"": ""Gene/Protein""}, {""token"": ""DR6"", ""start_span"": 84, ""end_span"": 87, ""type"": ""Gene/Protein""}, {""token"": ""immunoglobulins"", ""start_span"": 119, ""end_span"": 134, ""type"": ""Gene/Protein""}, {""token"": ""DR6"", ""start_span"": 168, ""end_span"": 171, ""type"": ""Gene/Protein""}, {""token"": ""cytokines"", ""start_span"": 232, ""end_span"": 241, ""type"": ""Gene/Protein""}, {""token"": ""transcriptional factors"", ""start_span"": 347, ""end_span"": 370, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor of activated T cells"", ""start_span"": 383, ""end_span"": 418, ""type"": ""Gene/Protein""}, {""token"": ""NFAT"", ""start_span"": 421, ""end_span"": 425, ""type"": ""Gene/Protein""}, {""token"": ""nuclear factor - kappa B"", ""start_span"": 430, ""end_span"": 454, ""type"": ""Gene/Protein""}, {""token"": ""NF\u03baB"", ""start_span"": 457, ""end_span"": 461, ""type"": ""Gene/Protein""}]"	train
Within the starch sub - network, the arrows indicated where the starch synthases ( SS1, SS2, SS3, SS4 ), starch branching enzymes ( SBE2. 1, SBE2. 2 ), isoamylase ( ISA3) and ADP glucose pyrophosphorylase in large and small subunit ( APL1, APS1) resided.	starch synthases,64,80,Gene/Protein	SS1,83,86,Gene/Protein	SS2,88,91,Gene/Protein	SS3,93,96,Gene/Protein	SS4,98,101,Gene/Protein	starch branching enzymes,105,129,Gene/Protein	isoamylase,152,162,Gene/Protein	ISA3,165,169,Gene/Protein	ADP glucose pyrophosphorylase,175,204,Gene/Protein	APL1,234,238,Gene/Protein	APS1,240,244,Gene/Protein	"[{""token"": ""starch synthases"", ""start_span"": 64, ""end_span"": 80, ""type"": ""Gene/Protein""}, {""token"": ""SS1"", ""start_span"": 83, ""end_span"": 86, ""type"": ""Gene/Protein""}, {""token"": ""SS2"", ""start_span"": 88, ""end_span"": 91, ""type"": ""Gene/Protein""}, {""token"": ""SS3"", ""start_span"": 93, ""end_span"": 96, ""type"": ""Gene/Protein""}, {""token"": ""SS4"", ""start_span"": 98, ""end_span"": 101, ""type"": ""Gene/Protein""}, {""token"": ""starch branching enzymes"", ""start_span"": 105, ""end_span"": 129, ""type"": ""Gene/Protein""}, {""token"": ""isoamylase"", ""start_span"": 152, ""end_span"": 162, ""type"": ""Gene/Protein""}, {""token"": ""ISA3"", ""start_span"": 165, ""end_span"": 169, ""type"": ""Gene/Protein""}, {""token"": ""ADP glucose pyrophosphorylase"", ""start_span"": 175, ""end_span"": 204, ""type"": ""Gene/Protein""}, {""token"": ""APL1"", ""start_span"": 234, ""end_span"": 238, ""type"": ""Gene/Protein""}, {""token"": ""APS1"", ""start_span"": 240, ""end_span"": 244, ""type"": ""Gene/Protein""}]"	train
